Neurotic, stress-related and somatoform disorders

F5_NEUROTIC

neurotic disorder: A form of functional mental illness that manifests in distressed emotional reactions such as anxiety, obsessive thoughts, compulsive behaviors, or irrational fears.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_ALLANXIOUS F5_PTSD F5_STRESSOTH F5_DISSOCIATIVE F5_SOMATOFORM F5_NEUROTICOTH	58439
6. Filter based on genotype QC (FinnGen only)	58439

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_NEUROTIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ALLANXIOUS\|F5_PTSD\|F5_STRESSOTH\|F5_DISSOCIATIVE\|F5_SOMATOFORM\|F5_NEUROTICOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neurotic, stress-related and somatoform disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	58439	40521	17918
Unadjusted period prevalence (%)	12.00	13.81	7.90
Median age at first event (years)	36.77	36.17	38.14

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
35638: Matched controls
283278

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

22.4

323.0

1176

431

G44.2

ICD-10 Finland

Tension-type headache

2.3

323.0

4909

18164

N06AX26

ATC

vortioxetine; oral

5.5

323.0

3196

5010

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

323.0

24622

158206

A02BC05

ATC

esomeprazole; systemic

1.7

323.0

13965

79116

F41.8

ICD-10 Finland

Other specified anxiety disorders

13.2

323.0

1586

995

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.0

323.0

1003

1349

T36

ICD-10 Finland

Poisoning by systemic antibiotics

9.3

323.0

3343

3102

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.2

323.0

1016

1341

Z71.8

ICD-10 Finland

Other specified counselling

2.0

323.0

8167

36892

A01

ICPC

Pain general/multiple sites

2.6

323.0

2731

8858

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

323.0

7275

35049

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

323.0

1041

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

323.0

9987

49691

A04

ICPC

Weakness/tiredness general

2.3

323.0

4122

14953

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

323.0

21464

139730

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

19.0

323.0

7627

4003

N06AX03

ATC

mianserin; oral

5.4

323.0

2867

4518

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

25.8

323.0

4250

1480

N06AA04

ATC

clomipramine; systemic

8.7

323.0

1195

1128

N05AH02

ATC

clozapine; systemic

5.6

323.0

1101

1614

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

323.0

490

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

12.5

323.0

977

635

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

6.8

323.0

1484

1789

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

60.2

323.0

951

129

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

6.5

323.0

5482

7739

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

12.2

323.0

1459

988

N06AB03

ATC

fluoxetine; oral

4.6

323.0

7581

15645

R42

ICD-10 Finland

Dizziness and giddiness

1.9

323.0

7046

32045

F61.0

ICD-10 Finland

Mixed personality disorders

18.4

323.0

1519

682

P76

ICPC

Depressive disorder

5.8

323.0

3517

5216

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.1

323.0

6431

7537

N05BA06

ATC

lorazepam; systemic, sublingual

5.3

323.0

2806

4508

N03AG01

ATC

valproic acid; systemic, rectal

5.2

323.0

3643

6072

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

323.0

8090

39508

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

323.0

13685

79633

IGY02

NOMESCO Finland

Psychiatric monitoring contact

10.9

323.0

1378

1042

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

11.9

323.0

700

478

N05AA02

ATC

levomepromazine; systemic

8.0

323.0

3064

3310

N06AA06

ATC

trimipramine; systemic

5.1

323.0

1316

2100

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

11.4

323.0

1251

897

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

323.0

16848

99030

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

323.0

9403

44855

P15

ICPC

Chronic alcohol abuse

4.6

323.0

1468

2609

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

14963

80955

R06.0

ICD-10 Finland

Dyspnoea

1.9

323.0

8205

37729

K02.1

ICD-10 Finland

Caries of dentine

1.7

323.0

19722

120014

P01

ICPC

Feeling anxious/nervous/tense

5.8

323.0

5197

8033

N06AB05

ATC

paroxetine; oral

5.8

323.0

4092

6161

N06AX21

ATC

duloxetine; oral

4.6

323.0

6499

13188

N05AD01

ATC

haloperidol; systemic

4.5

323.0

1303

2393

N06AG02

ATC

moclobemide; oral

5.1

323.0

2599

4301

N06AB08

ATC

fluvoxamine; oral

5.6

323.0

1631

2394

N03AF01

ATC

carbamazepine; oral, rectal

3.1

323.0

2067

5539

N05AN01

ATC

lithium; oral

6.9

323.0

1493

1781

F60.9

ICD-10 Finland

Personality disorder, unspecified

19.7

323.0

1094

454

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

6.4

323.0

2497

3318

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

323.0

5547

23778

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

323.0

6794

30681

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

13.7

323.0

728

431

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.8

323.0

3901

7054

N05AF03

ATC

chlorprothixene; systemic

7.9

323.0

1898

2005

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

9.0

323.0

1758

1631

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

8.7

323.0

6223

6699

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

11.8

323.0

1437

1009

N05AX08

ATC

risperidone; systemic

5.3

323.0

4348

7295

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

12.6

323.0

1794

1185

N05BA04

ATC

oxazepam; oral

5.1

323.0

14836

34496

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

323.0

5590

23801

A02BC02

ATC

pantoprazole; systemic

1.8

323.0

22724

138467

N03AX09

ATC

lamotrigine; oral

7.5

323.0

3073

3524

F32.9

ICD-10 Finland

Depressive episode, unspecified

8.2

323.0

9333

11736

F43.01

ICD-10 Finland

Acute stress reaction moderate

10.3

323.0

906

718

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

7.6

323.0

1124

1215

F31.8

ICD-10 Finland

Other bipolar affective disorders

10.0

323.0

1114

908

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

12.3

323.0

877

580

N06AX05

ATC

trazodone; oral

7.1

323.0

1530

1775

WX290

NOMESCO Finland

Other blockade of nerve

1.7

323.0

15181

87596

A02BC03

ATC

lansoprazole; oral

1.7

323.0

9878

52195

R51.80

ICD-10 Finland

Headache

2.5

323.0

5660

19949

SPAT1240

SPAT

Therapeutic discussion

4.2

323.0

5266

11166

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

10.3

323.0

971

765

WX110

NOMESCO Finland

Local anesthesy

1.7

323.0

23720

153180

SPAT1307

SPAT

Psychosocial counselling and guidance

4.4

323.0

2275

4285

F51.0

ICD-10 Finland

Nonorganic insomnia

3.1

323.0

5828

16924

F32.1

ICD-10 Finland

Moderate depressive episode

5.0

323.0

2732

4635

F41.1

ICD-10 Finland

Generalized anxiety disorder

30.2

323.0

4383

1311

F29

ICD-10 Finland

Unspecified nonorganic psychosis

7.3

323.0

2509

2902

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

323.0

4848

13306

30088

ICD-8 Finland

Neuroses, Other

+∞

323.0

565

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

12.2

323.0

1154

774

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

85.1

323.0

444

R03AC02

ATC

salbutamol; inhalant

1.6

323.0

17784

107320

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

126.2

323.0

470

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

323.0

17858

110542

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

8.6

323.0

842

792

F43.29

ICD-10 Finland

Adaptation disorder UNS

28.3

323.0

1969

585

N05BA12

ATC

alprazolam; oral

5.0

323.0

6615

12250

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

23.2

323.0

979

344

F40.1

ICD-10 Finland

Social phobias

49.5

323.0

2103

358

F41.3

ICD-10 Finland

Other mixed anxiety disorders

21.2

323.0

825

316

F34.1

ICD-10 Finland

Dysthymia

10.4

323.0

2690

2214

N05AF01

ATC

flupentixol; systemic

7.0

323.0

966

1126

F45.0

ICD-10 Finland

Somatization disorder

83.8

323.0

458

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

12.6

323.0

3181

2178

N06AX16

ATC

venlafaxine; oral

6.1

323.0

9821

16615

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

10.0

323.0

1236

1016

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

12.2

323.0

4052

2939

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

37.4

323.0

1745

389

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

10.2

323.0

1451

1172

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.9

323.0

1625

1935

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

10.3

323.0

881

696

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

11.9

323.0

4480

3375

N06AX11

ATC

mirtazapine; oral

4.4

323.0

17589

51524

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.3

323.0

1696

1150

N06AB04

ATC

citalopram; systemic

5.0

323.0

13388

30485

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

9961

47991

F39

ICD-10 Finland

Unspecified mood [affective] disorder

9.6

323.0

953

809

A02BC01

ATC

omeprazole; systemic

1.8

323.0

9012

45408

N05AB03

ATC

perphenazine; systemic, rectal

6.7

323.0

2361

2983

A06AD11

ATC

lactulose; oral

2.3

323.0

4653

17343

N05CF02

ATC

zolpidem; oral

2.5

323.0

7628

28095

N05BA01

ATC

diazepam; systemic, rectal

4.4

323.0

7877

17190

F32

ICD-10 Finland

Depressive episode

4.2

323.0

2411

4848

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

10.1

323.0

1146

927

N05BE01

ATC

buspirone; oral

10.3

323.0

2314

1890

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

323.0

476

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

323.0

3258

10225

N03AX16

ATC

pregabalin; oral

2.6

323.0

10336

38324

M79.1

ICD-10 Finland

Myalgia

2.1

323.0

4406

17756

N07BB01

ATC

disulfiram; oral

5.0

323.0

2754

4667

N02BE01

ATC

paracetamol; systemic, rectal

1.7

323.0

29121

203995

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.4

323.0

1459

1437

L03

ICPC

Low back symptom/complaint

1.8

323.0

7993

38467

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

103.8

323.0

413

N05AX12

ATC

aripiprazole; systemic

7.8

323.0

2517

2731

F41.01

ICD-10 Finland

Severe panic disorder

121.8

323.0

439

N05CD07

ATC

temazepam; oral

3.7

323.0

6014

14671

N03AE01

ATC

clonazepam; systemic

5.4

323.0

3603

5777

F99

ICD-10 Finland

Mental disorder, not otherwise specified

8.8

323.0

1269

1189

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

9.2

323.0

1454

1310

N05AH04

ATC

quetiapine; oral

7.5

323.0

12218

18411

N05BA02

ATC

chlordiazepoxide; systemic

5.8

323.0

1351

1910

R53

ICD-10 Finland

Malaise and fatigue

2.4

323.0

7541

28105

C07AA05

ATC

propranolol; systemic

3.1

323.0

9212

28654

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

11.2

323.0

1403

1028

A02BA02

ATC

ranitidine; systemic

1.9

323.0

6590

30761

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

10.9

323.0

896

668

F40.2

ICD-10 Finland

Specific (isolated) phobias

37.8

323.0

493

105

R52.2

ICD-10 Finland

Other chronic pain

4.2

323.0

1538

2999

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

323.0

10993

59472

SPAT1254

SPAT

Administration of medicine

2.1

323.0

4549

18768

F45.8

ICD-10 Finland

Other somatoform disorders

5.0

323.0

3658

6345

P74

ICPC

Anxiety disorder/anxiety state

9.3

323.0

2124

1921

N06AB10

ATC

escitalopram; oral

4.6

323.0

11710

27205

F43.00

ICD-10 Finland

Acute stress reaction mild

10.8

323.0

1678

1294

N06AA09

ATC

amitriptyline; systemic

3.3

323.0

4821

12934

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

11.0

323.0

1494

1117

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

13.6

323.0

623

371

N06AX22

ATC

agomelatine; oral

7.9

323.0

1259

1303

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

10.2

323.0

5440

4930

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

24.3

323.0

8470

3584

N05AH03

ATC

olanzapine; systemic

7.9

323.0

4588

5199

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.7

323.0

732

556

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

12.3

323.0

778

512

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

9.1

323.0

2083

1921

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

14136

82320

P03

ICPC

Feeling depressed

4.7

323.0

4412

8186

F41.00

ICD-10 Finland

Moderate panic disorder

143.8

323.0

1558

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

83.5

323.0

487

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

11.9

323.0

1546

1071

N06AX12

ATC

bupropion; oral

6.5

323.0

3959

5368

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

11871

58940

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

323.0

4483

14531

N06AB06

ATC

sertraline; oral

6.0

323.0

7231

11594

N03AX12

ATC

gabapentin; oral

2.6

323.0

6581

22548

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

13856

77100

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

323.0

19378

118091

F43.1

ICD-10 Finland

Post-traumatic stress disorder

32.1

323.0

1769

461

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

10.1

323.0

2616

2201

AA1AD

NOMESCO Finland

CT of head and brain

1.9

323.0

7805

36059

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

19.6

323.0

669

276

P06

ICPC

Sleep disturbance

2.6

323.0

3764

12413

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.2

323.0

1039

1172

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

323.0

13100

60686

N06AA12

ATC

doxepin; systemic

4.6

323.0

2905

5364

P99

ICPC

Psychological disorders other

6.8

323.0

1560

1885

EBA00

NOMESCO Finland

Extraction of tooth

1.7

323.0

10843

58299

IGY99

NOMESCO Finland

Other psychiatric treatment contact

12.5

323.0

1086

709

M79.6

ICD-10 Finland

Pain in limb

1.8

323.0

12377

64664

F41.09

ICD-10 Finland

UNS Panic Syndrome

29.1

323.0

2464

720

P29

ICPC

Psychological sympt/compl other

5.4

323.0

2965

4652

F43.2

ICD-10 Finland

Adjustment disorders

9.2

323.0

872

767

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

59.8

323.0

1532

213

F43.8

ICD-10 Finland

Other reactions to severe stress

7.9

323.0

1117

1149

N05CF01

ATC

zopiclone; oral

3.0

323.0

14447

53091

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

323.0

2996

8949

F60.5

ICD-10 Finland

Anankastic personality disorder

11.3

322.3

660

471

F32.8

ICD-10 Finland

Other depressive episodes

8.0

321.0

794

801

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

320.9

3016

10367

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.8

320.6

1004

1416

N04AA02

ATC

biperiden; systemic

5.4

320.4

1059

1595

S06.0

ICD-10 Finland

Concussion

2.2

319.3

3578

13421

N01

ICPC

Headache

2.4

317.2

3179

11292

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.9

315.9

1140

1897

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

9.7

315.6

699

582

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

315.3

5697

25971

P01AB01

ATC

metronidazole; oral, rectal

1.6

314.8

13015

75686

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.0

313.3

1110

1810

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.6

312.9

1580

3611

R11

ICD-10 Finland

Nausea and vomiting

2.6

309.2

2643

8623

R74

ICPC

Upper respiratory infection acute

1.7

307.9

8869

46822

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

55.8

306.5

395

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

305.1

9237

49426

M79.7

ICD-10 Finland

Fibromyalgia

3.8

304.9

1437

3098

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

14.1

304.2

564

322

KMAK

NOMESCO Finland

1.5

303.6

17302

108229

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

300.3

19393

124654

F10.24

ICD-10 Finland

Alcohol depence active use

6.6

299.9

848

1045

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

299.6

3794

15011

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

299.4

6789

33328

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

296.5

8188

42627

L28

ICPC

Limited function/disability (L)

2.0

296.5

4664

20156

R21

ICPC

Throat symptom/complaint

1.8

294.9

5861

27540

R52.9

ICD-10 Finland

Pain, unspecified

2.3

293.6

2961

10529

N05AC02

ATC

thioridazine; oral

5.1

293.2

1023

1639

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

291.6

4908

21743

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

290.0

5120

23076

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

289.3

2709

9270

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

288.6

4436

18986

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

288.0

5638

26337

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

287.0

2208

6767

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

284.8

3192

11938

D11

ICPC

Diarrhoea

2.1

283.4

3575

14099

L17

ICPC

Foot/toe symptom/complaint

1.7

282.7

7829

40696

F33

ICD-10 Finland

Recurrent depressive disorder

6.1

281.5

842

1119

C07AB07

ATC

bisoprolol; oral

1.5

280.4

13985

84301

G47.3

ICD-10 Finland

Sleep apnoea

1.7

280.0

7337

37519

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.8

278.6

1018

1715

3092D

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]

+∞

278.3

292

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.1

278.1

746

852

SPAT1243

SPAT

Psychiatric/psychological examination

4.5

277.5

1079

1940

J01DB01

ATC

cefalexin; oral

1.6

277.0

27567

193577

-1

NOMESCO Finland

1.6

276.5

10833

61630

AA400

NOMESCO Finland

Electroconvulsive therapy

11.9

275.8

550

371

M25.5

ICD-10 Finland

Pain in joint

1.6

275.0

9380

51520

F43.0

ICD-10 Finland

Acute stress reaction

3.2

274.8

1630

4208

J02AC01

ATC

fluconazole; systemic

1.5

273.8

12744

75482

N05AL01

ATC

sulpiride; systemic

6.0

272.7

831

1131

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

8.0

272.0

672

676

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

+∞

270.7

284

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

270.7

5682

27102

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

268.4

12524

74123

J01DA01

ATC

[U] cefalexin; systemic

1.5

268.0

20863

137972

N02AA05

ATC

oxycodone; systemic

1.9

267.2

4303

18701

M03BX02

ATC

tizanidine; oral

1.5

266.9

21270

141305

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

266.5

6890

35019

L01

ICPC

Neck symptom/complaint

1.9

265.3

4353

19046

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

264.5

1836

5272

N06BA04

ATC

methylphenidate; oral

5.5

262.6

856

1266

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

8.9

261.0

606

549

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

75.7

260.2

321

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

257.4

8252

44450

F22.0

ICD-10 Finland

Delusional disorder

5.9

256.7

787

1079

P72

ICPC

Schizophrenia

4.8

254.7

929

1561

F60.8

ICD-10 Finland

Other specific personality disorders

15.7

253.9

451

231

SPAT1263

SPAT

Sampling

1.5

253.9

12925

77722

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

253.6

8753

48022

3092E

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]

+∞

253.5

266

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

251.4

5505

26545

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

250.3

15069

93839

R02

ICPC

Shortness of breath/dyspnoea

2.0

246.7

3620

15145

N05AB01

ATC

dixyrazine; systemic

6.7

246.3

683

818

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

246.1

1934

5985

R07.3

ICD-10 Finland

Other chest pain

2.1

246.0

3112

12244

D01

ICPC

Abdominal pain/cramps general

2.1

241.4

3219

12946

K07.60

ICD-10 Finland

Snapping jaw

2.8

241.0

1711

4977

F31

ICD-10 Finland

Bipolar affective disorder

7.4

240.4

625

681

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

11.7

240.1

484

334

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

12.7

238.6

463

294

SPAT1301

SPAT

No procedures

1.6

238.6

9330

52629

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.9

238.0

649

759

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

515.3

237.8

258

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

237.0

6047

30474

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

236.0

2442

8756

N05AA01

ATC

chlorpromazine; systemic, rectal

5.6

234.1

747

1076

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

233.8

11713

69820

Z00.0

ICD-10 Finland

General medical examination

1.7

233.5

5601

27703

P25

ICPC

Phase of life problem adult

3.2

233.3

1338

3363

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

233.0

7015

37003

H02AB06

ATC

prednisolone; systemic

1.5

231.8

14629

91472

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

231.4

6421

33114

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.3

231.1

769

1165

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

230.7

6388

32920

XA800

NOMESCO Finland

Neuropsychological investigation

2.8

230.3

1608

4626

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

229.5

2639

9941

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.2

228.4

670

867

SPAT1234

SPAT

Support of social functional capacity

2.9

227.9

1582

4533

30530

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Cardiovascular

+∞

227.8

239

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

22.7

227.0

356

126

30050

ICD-8 Finland

Neuroses, Neurasthenia

+∞

226.8

238

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

225.9

8953

50529

K59.0

ICD-10 Finland

Constipation

2.7

225.8

1756

5396

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.6

224.9

634

777

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

224.7

4839

23125

R06AE07

ATC

cetirizine; oral

1.5

223.9

13991

87101

F60.7

ICD-10 Finland

Dependent personality disorder

22.0

223.8

354

129

F33.8

ICD-10 Finland

Other recurrent depressive disorders

12.1

223.5

443

295

SPAT1283

SPAT

Restricted health certificate

1.7

222.9

5142

25099

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

222.7

3880

17268

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.4

222.3

2190

7653

R05

ICPC

Cough

1.6

222.3

6671

35096

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

13.4

222.3

421

253

P16

ICPC

Acute alcohol abuse

5.0

221.3

776

1248

UJF32

NOMESCO Finland

Coloscopy

1.6

219.8

7810

42883

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

8.6

219.6

521

490

L02

ICPC

Back symptom/complaint

2.1

217.3

2852

11367

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

216.8

2325

8467

30041

ICD-8 Finland

Neuroses, Depressiva

6.5

216.1

614

761

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

215.5

11964

72539

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

214.4

3215

13522

J01FF01

ATC

clindamycin; systemic

1.5

214.3

8575

48389

F61

ICD-10 Finland

Mixed and other personality disorders

15.5

213.8

381

197

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

213.1

4071

18681

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

211.1

1716

5406

V03AA01

ATC

4.7

209.7

784

1351

3009X

ICD-9 Finland

Neurotic disorders, Unspecified neurotic disorder

+∞

209.6

220

A28

ICPC

Limited function/disability NOS

1.9

209.5

3811

17190

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.3

207.2

604

775

N03AX11

ATC

topiramate; oral

3.8

207.0

978

2105

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

136.6

205.9

239

Z01.2

ICD-10 Finland

Dental examination

1.4

205.1

12940

80261

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

204.5

2797

11329

30010

ICD-8 Finland

Neuroses, Hysterical neurosis

+∞

203.9

214

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

203.5

3981

18394

N06AX18

ATC

reboxetine; oral

5.9

203.1

619

842

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

19.3

202.5

334

139

P18

ICPC

Medication abuse

14.2

202.4

374

212

K30

ICD-10 Finland

Functional dyspepsia

1.9

202.2

3321

14434

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.0

202.1

1298

3530

H03AA01

ATC

levothyroxine sodium; systemic

1.6

202.1

7137

38999

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

201.7

9211

53403

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.8

201.0

504

519

P02

ICPC

Acute stress reaction

2.9

200.8

1359

3827

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

200.5

4318

20570

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

200.4

3772

17200

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

200.3

3553

15871

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

19.2

199.8

330

138

N05AD03

ATC

melperone; systemic

6.1

198.8

591

778

N06AX17

ATC

milnacipran; oral

5.9

198.3

605

824

WZA90

NOMESCO Finland

Other doctors statement

1.6

197.5

7116

39038

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

62.3

196.8

249

SPAT1216

SPAT

Assessment of functional ability

1.8

196.4

4171

19773

R00.2

ICD-10 Finland

Palpitations

2.2

196.3

2282

8613

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.7

195.1

616

876

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

25.0

195.0

297

P27

ICPC

Fear of mental disorder

7.2

194.7

515

576

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

22.2

193.5

305

110

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

193.4

11791

72404

SPAT1310

SPAT

Counselling related to known health issue

1.5

193.3

9310

54494

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.8

192.8

596

825

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.5

192.6

1008

2360

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

192.3

3209

14014

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

192.3

13316

83753

IGV01

NOMESCO Finland

Psychiatric network contact

10.9

190.3

395

290

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

15.0

190.2

343

183

IEY01

NOMESCO Finland

Psychoeducation, individual

13.0

189.9

364

225

IBA03

NOMESCO Finland

Psychotherapy evaluation

14.9

188.7

341

183

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

187.9

3891

18275

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

8.2

187.8

456

446

T74.1

ICD-10 Finland

Physical abuse

4.3

186.7

758

1420

S18

ICPC

Laceration/cut

1.4

186.0

12535

78288

F41

ICD-10 Finland

Other anxiety disorders

5.9

186.0

571

784

3000C

ICD-9 Finland

Neurotic disorders, Anxiety states[YLEISTYNYT TUSKAISUUS]

+∞

185.8

195

E0000UV

ATC

1.4

185.5

11885

73512

R4110

NOMESCO Finland

Physiotherapy

1.5

185.4

8138

46608

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

184.5

8313

47873

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.3

184.5

1033

2546

F43.02

ICD-10 Finland

Acute stress reaction severe

21.7

183.9

292

108

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

13.6

182.4

342

201

3000B

ICD-9 Finland

Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]

+∞

182.0

191

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

181.9

14196

90950

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

5.8

181.7

565

788

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

180.9

1809

6351

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

9.1

180.8

413

364

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

13.5

180.1

339

201

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

180.0

1558

5073

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

179.9

3182

14168

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

178.3

8434

49010

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

23.8

177.5

274

F40.8

ICD-10 Finland

Other phobic anxiety disorders

38.3

177.3

244

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

16.6

177.0

307

148

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

10.8

176.4

368

273

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.1

175.9

1077

2832

M01AE02

ATC

naproxen; oral, rectal

1.4

175.7

18046

120965

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

14.1

175.3

324

184

R50.9

ICD-10 Finland

Fever, unspecified

1.7

174.8

4046

19640

L12

ICPC

Hand/finger symptom/complaint

1.7

173.6

4219

20773

A03FA02

ATC

cisapride; oral, rectal

2.0

173.6

2394

9702

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.5

173.1

387

328

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

7.8

172.9

434

448

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

172.9

2432

9935

M54.2

ICD-10 Finland

Cervicalgia

2.1

172.2

2281

9093

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

15.7

171.6

304

155

R13

ICD-10 Finland

Dysphagia

2.2

171.6

1953

7289

SPAT1260

SPAT

Consultation of another employee

1.6

170.9

5070

26369

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

170.7

1911

7075

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

9.9

170.6

372

301

R4140

NOMESCO Finland

Psychotherapy

12.8

169.3

326

204

N17

ICPC

Vertigo/dizziness

1.9

169.1

3020

13476

F60.0

ICD-10 Finland

Paranoid personality disorder

19.1

168.9

279

117

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

168.7

2067

7969

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

168.1

1752

6272

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

167.2

3668

17500

N03AF02

ATC

oxcarbazepine; oral

2.9

166.7

1102

3049

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

166.5

2995

13395

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

166.5

1583

5413

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

165.4

2871

12679

J01CA04

ATC

amoxicillin; systemic

1.4

165.1

26463

190256

S29

ICPC

Skin symptom/complaint other

1.6

165.0

4733

24372

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

59.7

164.3

209

N30.0

ICD-10 Finland

Acute cystitis

1.7

164.1

3658

17529

N05CD02

ATC

nitrazepam; oral

4.5

164.0

642

1160

J01FA06

ATC

roxithromycin; oral

1.4

163.9

12621

80192

R01AD09

ATC

mometasone; nasal

1.4

163.9

14108

91368

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

12.4

163.3

319

206

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.1

163.1

706

1405

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.3

162.7

470

596

30020

ICD-8 Finland

Neuroses, Phobic neurosis

+∞

161.9

170

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

161.6

3186

14686

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

161.2

1792

6609

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.8

160.6

442

524

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.1

160.1

550

864

F32.0

ICD-10 Finland

Mild depressive episode

3.4

160.0

857

2041

SPAT1312

SPAT

General health counselling

1.4

159.8

9007

53990

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

159.8

6023

33164

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

159.7

22195

155154

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

159.6

4681

24227

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

158.7

3206

14888

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

8.6

158.1

373

348

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

158.0

1824

6843

F21

ICD-10 Finland

Schizotypal disorder

8.4

157.9

377

359

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.2

157.7

461

594

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

157.1

4767

24883

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

156.3

4654

24174

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

156.1

3243

15191

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

156.1

1831

6918

D10

ICPC

Vomiting

2.3

154.3

1555

5471

C03CA01

ATC

furosemide; systemic

1.5

153.1

6856

39163

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

153.1

1540

5414

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

152.7

2377

10078

N06AA10

ATC

nortriptyline; systemic

3.3

152.6

839

2039

SGA01

NOMESCO Finland

Tooth opening as first aid

1.6

152.5

4997

26573

J01EA01

ATC

trimethoprim; systemic

1.5

152.4

6917

39622

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

152.3

6955

39890

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

152.2

7707

45152

Z08

ICPC

Social welfare problem

4.9

151.7

538

876

A05

ICPC

Feeling ill

2.2

151.7

1641

5972

R06.4

ICD-10 Finland

Hyperventilation

4.2

151.5

633

1219

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4890

19385

1.87

316.34

3.0

3.4

4.5

pmol/l

2.96

4243

17486

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8373

38800

1.63

312.98

2.6

2.4

g/l

16.50

7665

36031

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

649

796

5.85

310.04

2.3

2.5

148.8

152.8

nmol/l

0.28

563

688

(3009261) Glucose [Presence] in Urine by Test strip

25989

150984

1.43

307.65

4.1

3.4

0.0

estimate

0.07

5143

27601

(3016879) Cocaine [Presence] in Urine

5927

12709

3.60

307.65

3.0

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

27897

146202

1.74

307.65

7.1

6.0

29.1

28.8

6.80

26094

137071

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13791

67677

1.60

307.65

1.8

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

16492

85614

1.53

307.65

3.5

3.2

7.9

8.0

mmol/l

0.37

14008

72979

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6643

25860

1.94

307.65

2.9

2.4

40.6

45.2

u/l

0.25

5694

22200

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

12859

37973

2.85

307.65

2.2

1.6

1.5

1.4

87.11

11447

33937

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7253

26422

2.10

307.65

2.3

1.9

—

(3026008) Bacteria identified in Urine by Culture

16125

82075

1.57

307.65

3.3

2.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

35874

207791

1.68

307.65

5.0

4.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

15334

69390

1.80

307.65

2.2

1.9

—

(3018010) Neutrophils/100 leukocytes in Blood

27587

144038

1.74

307.65

6.9

5.8

56.5

56.7

2.05

25868

135606

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10025

47216

1.63

307.65

2.7

3.0

2.4

mmol/l

27.42

8602

41418

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1438

1027

10.20

307.65

1.9

—

(3032080) INR in Blood by Coagulation assay

19443

107385

1.45

307.65

7.7

7.6

1.1

1.2

inr

17.48

6110

32070

(3009466) Valproate [Moles/volume] in Serum or Plasma

2184

3248

4.94

307.65

5.7

5.1

371.4

374.3

umol/l

0.34

1930

2830

(3007164) IgA [Mass/volume] in Serum or Plasma

13434

61627

1.73

307.65

1.5

1.4

2.2

2.3

g/l

8.33

7760

39002

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

23090

108080

1.91

307.65

2.1

1.8

97.7

97.2

pmol/l

0.82

12499

56256

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

37692

215072

1.82

307.65

4.1

2.8

46.3

44.4

u/l

3.76

35644

203060

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

45892

294686

1.72

307.65

4.7

4.0

5.9

5.8

mmol/l

13.97

42626

272630

(4198724)

1211

1009

8.70

307.65

2.5

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

49510

313920

2.50

307.65

18.2

13.4

3.9

4.0

mmol/l

91.68

48453

305079

(3024561) Albumin [Mass/volume] in Serum or Plasma

23710

118638

1.75

307.65

5.0

4.8

36.4

36.0

g/l

22.94

21981

110469

(3027008) Opiates [Presence] in Urine

6129

14029

3.38

307.65

3.0

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

9169

42388

1.65

307.65

1.4

479.0

559.9

titre

3.75

1686

8487

(3019069) Monocytes/100 leukocytes in Blood

27279

141107

1.76

307.65

7.4

6.2

8.3

8.5

25.56

25615

132951

(3033658) Prothrombin time (PT) actual/Normal

14705

72512

1.61

307.65

4.5

3.8

94.8

92.4

27.46

14247

70665

(3022948) Iron [Moles/volume] in Serum or Plasma

9078

42392

1.63

307.65

2.6

2.4

13.6

14.1

umol/l

0.55

8391

39476

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

47383

285152

2.51

307.65

6.0

4.5

1.8

2.1

mu/l

6.33

44638

264519

(3000764) Benzodiazepines [Presence] in Urine

6135

13886

3.42

307.65

3.0

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3219

9394

2.53

307.65

2.0

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19067

101721

1.51

307.65

4.0

3.1

46.9

58.4

ng/l

0.43

11299

61878

(3001122) Ferritin [Mass/volume] in Serum or Plasma

26834

136014

1.80

307.65

3.3

2.8

100.1

113.3

ug/l

8.76

25020

127537

(3020564) Creatinine [Moles/volume] in Serum or Plasma

50233

333283

2.06

307.65

18.3

13.5

72.6

74.5

umol/l

36.73

50223

333110

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7412

32420

1.72

307.65

2.9

2.7

6.6

8.2

umol/l

10.21

6143

28173

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19236

89340

1.83

307.65

3.1

2.5

55.1

58.1

u/l

9.16

17759

82604

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1198

1457

5.95

307.65

13.8

13.2

1263.4

1515.0

nmol/l

0.12

1165

1404

(40758558) Short blood count panel - Blood

15175

73785

1.64

307.65

7.9

6.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

50448

335523

2.09

307.65

12.4

9.3

27.7

26.8

u/l

10.97

49135

324841

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2434

5141

3.48

307.65

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7775

34051

1.73

307.65

6.4

6.0

1.0

mmol/l

0.62

7270

31912

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9167

41145

1.70

307.65

2.0

1.8

—

(3001604) Monocytes [#/volume] in Blood

29012

149100

1.83

307.65

7.0

5.8

0.6

e9/l

3.20

25261

130354

(3013115) Eosinophils [#/volume] in Blood

29900

154967

1.83

307.65

7.6

6.0

0.2

e9/l

4.79

26413

137489

(3013707) Erythrocyte sedimentation rate by Westergren method

38836

223477

1.84

307.65

4.5

3.8

10.6

11.0

mm/h

8.22

36246

208287

(3015377) Calcium [Moles/volume] in Serum or Plasma

19852

91275

1.86

307.65

3.0

3.4

2.4

mmol/l

4.16

17471

80598

(3048689) Calprotectin [Mass/mass] in Stool

9380

39556

1.83

307.65

2.4

2.5

118.9

132.2

ug/g

2.79

7188

31485

(3002582) Erythrocytes [#/volume] in Urine

16727

83347

1.62

307.65

3.6

3.0

52.0

83.3

e6/l

3.41

12918

62918

(3023368) Bacteria identified in Blood by Culture

14046

69653

1.59

307.65

4.8

4.1

—

(3011288) Drugs identified in Urine by Screen method

5318

8019

5.12

307.65

4.1

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

43066

239552

2.39

307.65

4.9

3.9

14.4

14.7

pmol/l

111.33

39996

219765

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

27660

134345

1.95

307.65

7.0

6.5

1.2

mmol/l

0.81

23786

113212

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17215

80716

1.76

307.65

2.5

2.0

211.0

205.5

u/l

0.18

16273

75879

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9853

43151

1.76

307.65

3.9

3.5

0.8

mmol/l

0.14

9174

40403

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

48976

314809

2.17

307.65

17.2

11.9

20.1

22.5

mg/l

50.04

39758

243868

(3030467) Casts [#/volume] in Urine by Automated count

15558

76038

1.64

307.65

3.5

2.9

0.3

0.4

e6/l

3.44

11781

56216

(3042517) Benzodiazepines panel - Urine

394

173

16.30

307.65

3.0

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

11421

41646

2.20

307.65

2.4

2.0

—

(3018418) pH of Serum or Plasma

17183

79043

1.80

307.65

4.2

4.1

7.4

4.56

3133

15185

(42870588) Differential panel, method unspecified - Blood

20440

99330

1.75

307.65

6.6

6.0

—

(3027944) Amphetamines [Presence] in Urine

5943

13904

3.29

307.65

2.9

1.7

—

(3021589) Normoblasts [#/volume] in Blood

24652

133978

1.57

307.65

10.6

8.9

0.0

e9/l

0.31

20144

110459

(3019550) Sodium [Moles/volume] in Serum or Plasma

49444

312845

2.51

307.65

18.2

13.2

139.5

139.7

mmol/l

66.33

48475

304667

(3019309) Folate [Moles/volume] in Red Blood Cells

11096

43934

2.00

307.65

1.8

1.7

1142.2

1176.7

nmol/l

3.46

8701

33429

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5847

21020

2.10

307.65

2.1

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

24383

121023

1.79

307.65

2.6

2.2

3732.1

76.4

nmol/l

0.50

22412

110487

(3026782) Osmolality of Urine

11347

52728

1.67

307.65

3.0

2.6

524.1

547.7

mosm/kgh2o

18.61

9720

44807

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

25317

121203

1.91

307.65

6.4

5.8

1.2

mmol/l

0.52

23246

110054

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

19456

98982

1.62

307.65

3.7

3.1

—

0.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

25776

149526

1.43

307.65

5.4

4.5

0.0

estimate

0.12

5252

28384

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

28952

147032

1.86

307.65

6.4

5.9

9.9

11.1

umol/l

58.21

27243

139193

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21762

97818

1.98

307.65

3.7

3.1

31.3

33.0

u/l

3.75

20624

93005

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

40580

225579

2.13

307.65

8.4

7.1

76.2

76.7

u/l

1.36

38440

212757

(3019198) Lymphocytes [#/volume] in Blood

29696

154558

1.82

307.65

7.0

5.8

2.0

1.9

e9/l

3.15

26343

137554

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

771

908

6.11

307.65

2.7

1.5

164.5

117.6

umol/l

2.17

378

470

(1001926) Buprenorphine [Presence] in Urine by Screen method

5417

10063

4.14

307.65

3.1

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

25824

148950

1.45

307.65

4.1

3.3

0.0

estimate

1.12

5089

27605

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11869

57671

1.59

307.65

1.8

1.7

—

(3019150) Specific gravity of Urine by Refractometry

13113

63334

1.62

307.65

4.2

3.7

1.0

kg/l

0.41

1662

9796

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1259

1536

5.94

307.65

18.8

18.9

1443.4

3491.6

nmol/l

0.97

1209

1464

(3006504) Eosinophils/100 leukocytes in Blood

27124

140338

1.75

307.65

7.1

6.0

2.8

2.9

13.85

25363

131437

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11526

56110

1.59

307.65

1.7

1.6

32140740.0

38569895.3

pmol/l

0.53

9779

47185

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15011

67091

1.82

307.65

2.4

2.2

2.8

2.9

mg/l

3.40

12898

57706

(3022096) Basophils/100 leukocytes in Blood

26381

135839

1.75

307.65

7.1

6.0

0.7

3.91

24652

127278

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13497

65115

1.63

307.65

2.0

1.7

1.0

1.1

mg/l

1.58

9836

49191

(3013826) Glucose [Moles/volume] in Serum or Plasma

30904

167551

1.73

307.65

5.6

4.4

6.5

6.6

mmol/l

14.14

28906

154652

(3000850) Epithelial cells [#/volume] in Urine

12041

57053

1.64

307.65

2.9

2.5

6.7

6.0

e6/l

5.70

10569

49654

(3028300) Cannabinoids [Presence] in Urine

6153

14058

3.38

307.65

3.0

1.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1285

1215

7.68

307.65

11.9

12.2

0.6

mmol/l

1.18

1186

1116

(3015736) pH of Urine

21741

113939

1.60

307.65

3.8

3.1

5.8

0.07

(3017143) Hepatitis C virus Ab [Presence] in Serum

9403

39982

1.81

307.65

1.8

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

32557

172745

1.86

307.65

11.2

8.7

4.1

4.0

e9/l

4.04

28561

151726

(3044889) 12 lead EKG panel

33830

204442

1.47

307.65

3.7

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

12311

46300

2.15

307.65

2.5

2.0

—

(36304419) Bacteria [Presence] in Urine

15393

74902

1.65

307.65

3.4

2.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7560

25739

2.27

307.65

2.1

2.2

372.0

374.4

nmol/l

0.44

6880

23862

(3023511) Choriogonadotropin [Units/volume] in Urine

2689

6979

2.83

307.65

1.5

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

13588

57912

1.89

307.65

1.6

1.5

20.1

20.5

nmol/l

2.83

12084

49891

(3021387) Prolactin [Units/volume] in Serum or Plasma

3866

12618

2.27

307.65

1.7

1.6

363.4

293.9

mu/l

8.11

3430

11444

(3018095) Leukocytes [#/volume] in Urine

19769

99934

1.64

307.65

4.2

3.4

74.2

86.8

e6/l

1.39

13856

68568

(3028707) Methadone [Presence] in Urine by Screen method

4433

3869

8.78

307.65

3.2

2.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

15464

71457

1.75

307.65

1.4

1.3

1.4

1.7

u/ml

2.77

3955

20042

(3006315) Basophils [#/volume] in Blood

29133

149730

1.83

307.65

7.0

5.8

0.0

e9/l

0.41

25332

130865

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

45360

290831

1.69

307.65

14.4

11.0

90.6

85.5

ml/min/173m2

307.65

37507

237885

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4368

14997

2.16

307.65

2.5

2.3

5960.7

6174.2

u/l

0.14

1433

6279

(3031040) Bacteria [#/volume] in Urine by Automated count

35008

195056

1.79

307.65

5.3

4.0

1319.3

1408.9

e6/l

0.10

459

2507

(3007853) Bacteria identified in Skin by Aerobe culture

7455

33713

1.66

305.88

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6422

27913

1.72

305.14

1.9

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9620

46394

1.58

303.82

2.9

2.6

1.2

1.1

e6/l

0.11

5222

25923

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

9076

43231

1.59

301.92

3.1

2.7

4.1

3.1

e6/l

6.98

4685

22917

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6376

27742

1.72

301.56

1.9

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

41756

267146

1.49

298.51

20.6

14.4

13.6

0.37

41111

261555

(36660697) Celiac disease serology panel - Serum

5895

25234

1.74

294.98

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10766

53578

1.54

294.62

1.3

31.2

33.8

iu/ml

0.28

2836

17214

(40768797) Stomach Pathology biopsy report

8297

38968

1.61

291.54

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

13053

67840

1.49

289.73

3.9

3.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1078

2157

3.60

289.55

1.8

1.3

1.5

1.4

promille

0.62

808

1686

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10283

51108

1.53

281.24

4.0

3.4

276.2

512.0

ng/l

5.81

6608

36673

(3014111) Lactate [Moles/volume] in Serum or Plasma

5280

22246

1.76

278.12

7.1

7.4

1.4

1.3

mmol/l

0.89

5047

21502

(40761511) CBC panel - Blood by Automated count

49616

331749

1.80

278.09

15.7

11.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

8396

40070

1.58

274.03

1.8

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5440

23298

1.73

270.21

4.7

3.9

5.9

5.8

kpa

8.83

5247

22650

(3002032) Base excess in Venous blood by calculation

5411

23230

1.73

266.23

4.7

4.0

1.9

1.8

mmol/l

0.87

4428

19092

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7643

35917

1.60

265.43

2.7

2.5

22.6

23.3

3.71

6594

30818

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

36493

229451

1.40

264.67

3.8

3.2

—

(3012544) pH of Venous blood

5556

24123

1.71

262.27

4.7

4.0

7.4

1.00

120

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1642

4502

2.64

260.51

1.6

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4621

19083

1.79

259.53

1.8

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10023

50636

1.50

249.78

1.3

7.7

11.6

u/ml

6.00

3646

20561

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

42578

276481

1.45

244.57

5.8

5.1

38.8

39.0

mmol/mol

4.89

39815

258631

(3042936) Bacteria identified in Isolate by Culture

8058

39025

1.55

243.66

2.2

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

4536

18991

1.76

242.37

4.1

3.3

4.8

4.7

kpa

3.83

4355

18402

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5746

25771

1.65

238.70

1.6

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1458

3939

2.68

237.82

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3909

15829

1.81

233.10

3.8

3.4

5.2

5.1

kpa

5.40

3642

14652

(3023323) Follitropin [Units/volume] in Serum or Plasma

4206

17430

1.78

232.25

1.4

1.3

23.4

27.3

iu/l

11.48

3489

15131

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5190

22860

1.68

230.50

1.2

125.1

146.5

iu/ml

3.23

1729

8951

(3009343) pH of Capillary blood

3857

15630

1.81

229.30

3.8

3.4

7.4

1.17

507

2053

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3747

15084

1.82

227.53

3.7

3.3

1.6

mmol/l

0.18

2779

11013

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5606

25327

1.64

225.49

2.6

2.3

0.2

g/l

9.03

5156

23717

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8254

40805

1.52

225.27

2.3

2.2

29.5

29.7

1.15

7990

39620

(3014576) Chloride [Moles/volume] in Serum or Plasma

6767

32032

1.57

224.50

7.6

7.3

104.3

104.5

mmol/l

3.42

6602

31403

(3000991) Gas panel - Venous blood

4936

21641

1.68

222.61

8.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3210

12386

1.90

222.37

5.0

4.4

24.2

mmol/l

0.03

2871

11221

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2115

7066

2.17

217.09

1.3

524.5

521.6

mg/l

0.03

2004

6747

(3023183) Ammonium ion [Moles/volume] in Plasma

1677

5082

2.39

215.96

2.8

2.9

33.1

34.7

umol/l

1.77

1451

4337

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3511

14087

1.83

215.06

1.7

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

16325

92414

1.37

210.15

2.6

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3686

15124

1.79

209.58

1.6

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2750

10295

1.95

207.98

1.4

9.6

u/l

0.07

2177

8523

(3000494) Fungus identified in Specimen by Culture

6976

33786

1.54

207.73

1.6

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

12903

70576

1.39

203.54

5.2

4.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1889

6210

2.20

201.48

1.3

3.7

mmol/l

0.01

1755

5843

(3005719) IgG [Mass/volume] in Serum or Plasma

4949

22253

1.64

201.44

2.7

10.2

10.6

g/l

6.52

4490

20437

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1891

6251

2.19

198.97

1.5

3208.8

1779.8

e6/l

0.32

1509

5077

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4039

17270

1.72

198.59

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1889

6247

2.19

198.55

1.4

27.3

31.3

e6/l

0.19

1421

4832

(3003396) Base excess in Arterial blood by calculation

6017

28488

1.56

197.43

7.8

7.5

1.1

1.0

mmol/l

1.79

4767

22393

(3027801) Oxygen [Partial pressure] in Arterial blood

6007

28471

1.56

196.09

7.7

7.5

12.3

12.9

kpa

10.50

5742

27181

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6008

28488

1.56

195.72

7.7

7.6

5.1

kpa

4.93

5749

27203

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4652

20751

1.65

195.03

2.4

2.3

22.7

23.2

au/ml

0.09

224

1402

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4302

18991

1.66

187.39

1.3

45.2

47.9

au/ml

0.22

106

820

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2144

7653

2.03

184.91

1.4

294.2

276.8

ug/g

2.23

1149

4426

(3013512) EKG study

13672

76687

1.36

180.40

3.9

3.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3084

12540

1.79

179.80

1.1

9.7

10.8

u/ml

0.05

194

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1603

5175

2.24

178.35

1.4

1.3

23.9

25.8

u/l

1.40

1291

4316

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

762

1680

3.26

176.76

1.8

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1748

5906

2.14

173.92

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2316

8686

1.94

173.56

2.3

2.4

387.5

536.7

ug/l

1.76

2121

8088

(3014765) Yersinia sp identified in Stool by Organism specific culture

2288

8587

1.93

171.06

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2292

8614

1.93

170.66

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2699

10713

1.83

169.97

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2721

10833

1.83

169.70

1.8

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

14017

79537

1.34

169.17

4.6

3.7

0.0

estimate

4.29

5122

27447

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2264

8509

1.93

168.52

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

4805

22405

1.58

166.63

8.8

7.8

8.1

9.2

mmol/l

26.06

4579

21423

(3025941) Bacteria identified in Stool by Culture

4045

18153

1.63

164.22

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

51904

357233

1.91

163.30

25.9

17.4

261.6

255.3

e9/l

91.48

50930

348485

(3016502) Oxygen saturation in Arterial blood

5305

25406

1.54

163.28

8.2

8.0

95.6

95.9

3.48

5130

24412

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12463

69878

1.35

161.39

2.5

2.2

—

(3019225) pH of Specimen

5321

25599

1.53

160.20

4.3

4.0

—

(3035941) MCH [Entitic mass]

51910

357584

1.88

156.74

25.8

17.3

30.2

5.62

51409

353131

(3024731) MCV [Entitic volume]

51914

357623

1.88

156.68

25.8

17.3

90.4

90.5

3.01

51411

353158

(3005322) IgE [Units/volume] in Serum or Plasma

4430

20561

1.58

156.17

1.4

1.3

257.6

242.4

u/ml

0.21

4075

19071

(3026361) Erythrocytes [#/volume] in Blood

51916

357667

1.88

156.11

25.9

17.3

4.5

e12/l

20.65

50848

348051

(3010813) Leukocytes [#/volume] in Blood

51923

357754

1.88

155.59

26.0

17.4

6.9

6.6

e9/l

73.14

50853

348111

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2892

12035

1.75

155.19

1.3

1.2

0.6

0.9

u/ml

0.86

232

1031

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

23247

142587

1.28

153.71

4.2

3.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

51920

357815

1.88

153.66

26.1

17.4

135.5

136.5

g/l

42.89

51421

353406

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3632

16230

1.63

149.41

7.3

7.4

24.9

24.8

mmol/l

1.75

3597

16093

(3028026) IgM [Mass/volume] in Serum or Plasma

3800

17248

1.61

146.66

1.9

1.8

1.3

g/l

0.02

3470

15823

(3048929) Epstein Barr virus Ab [Presence] in Serum

2707

11284

1.74

144.15

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

598

1297

3.30

142.34

1.9

1.5

1938474.9

1807306.9

iu/ml

0.09

(3013139) Helicobacter pylori Ag [Presence] in Stool

4290

20185

1.55

141.84

1.2

—

(3022313) Gas panel - Capillary blood

2693

11283

1.73

140.77

4.0

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

19324

116992

1.27

136.40

4.3

3.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4862

23741

1.50

135.08

8.6

8.4

123.3

122.0

g/l

4.32

4703

22853

(3052851) Hemolysis interference index of Serum or Plasma

2056

8064

1.84

133.87

3.0

3.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2405

9960

1.75

130.73

4.1

3.6

24.7

24.8

mmol/l

0.48

2275

9251

(3027945) Reticulocytes/100 erythrocytes in Blood

5483

27661

1.46

128.96

2.8

2.6

1.8

0.12

4833

24696

(3019060) Gas panel - Arterial blood

3489

15993

1.59

128.61

5.4

4.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4478

21713

1.51

128.31

4.1

3.7

1.2

mmol/l

2.59

3910

18997

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

13237

76899

1.30

127.51

1.7

1.6

1.5

1.4

mmol/l

42.93

11479

65358

(3017181) Myelocytes/100 leukocytes in Blood

4880

24169

1.48

125.95

4.4

4.1

0.9

0.03

1334

6396

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11969

68708

1.31

125.75

3.1

2.8

998.5

1174.1

ng/l

3.37

9770

57912

(3004716) Salmonella sp identified in Stool by Organism specific culture

3735

17562

1.55

123.09

1.3

1.4

—

(21494755) Public health laboratory ask at order entry panel

4056

41367

0.67

119.44

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2641

11500

1.66

119.36

3.8

2.9

1.6

1.3

20.47

2625

11445

(3007463) Buprenorphine [Presence] in Urine

131

14.81

119.08

7.6

9.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2194

9113

1.74

117.81

1.9

1.7

0.2

g/l

0.82

2070

8659

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2243

9396

1.73

116.87

1.8

1.7

1.2

g/l

0.83

2122

8959

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4491

22193

1.48

116.72

2.5

2.2

12.0

12.7

nmol/l

6.01

3921

20131

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1454

5328

1.97

115.95

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1454

5331

1.96

115.76

1.4

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

4628

23064

1.47

115.16

4.5

4.2

0.1

0.14

1212

5946

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1843

7322

1.82

114.93

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6323

33372

1.39

114.67

7.4

6.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4038

19641

1.50

113.30

3.9

4.0

85.0

88.0

ng/l

1.10

3499

17166

(3020961) Endomysium IgA Ab [Titer] in Serum

3369

15779

1.55

112.61

1.1

158.9

199.8

titre

0.39

451

(3002179) Metamyelocytes/100 leukocytes in Blood

4437

22100

1.47

110.48

4.2

4.0

0.7

0.08

959

4673

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2561

11282

1.64

110.47

3.8

2.9

0.7

0.41

2460

10827

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

240

310

5.52

109.17

1.2

1.1

—

(4010399)

4163

20568

1.48

107.89

1.4

—

(3023410) Appearance of Cerebral spinal fluid

909

2859

2.28

107.30

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3213

15047

1.55

107.27

4.1

3.4

131.3

129.9

g/l

2.87

3137

14698

(1616796) Gas panel - Central venous blood

1498

5727

1.88

105.34

3.9

3.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1536

5932

1.87

104.70

3.5

3.1

8.8

8.5

kpa

6.10

1442

5507

(3003181) Sodium [Moles/volume] in Urine

1145

3998

2.06

104.26

1.5

1.4

59.4

64.8

mmol/l

3.52

890

3148

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2858

13117

1.58

104.11

9.4

10.1

24.4

24.3

mmol/l

0.71

2636

12342

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

10118

58047

1.29

103.48

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1351

5024

1.93

103.18

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3307

15729

1.53

102.77

9.6

1.5

1.4

12.49

3293

15625

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3303

15712

1.53

102.58

9.7

0.7

0.23

3290

15620

(40761535) Cells panel - Urine sediment

4330

21765

1.45

102.42

3.9

3.3

—

(3025159) Blasts/100 leukocytes in Blood

4357

21936

1.45

102.18

4.6

4.2

0.1

0.2

2.66

1025

5071

(3022145) Colonoscopy Study observation

6183

33087

1.37

102.14

1.3

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1587

6250

1.83

101.68

3.2

2.9

24.7

24.6

mmol/l

0.39

1419

5495

(3007566) Smooth muscle Ab [Titer] in Serum

2012

8508

1.71

101.12

1.3

81.2

123.8

titre

3.28

169

810

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2559

11539

1.60

100.30

1.6

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3305

15827

1.52

99.39

9.7

93.7

94.1

3.44

3293

15765

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

200

238

5.99

98.55

6.8

8.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1420

5454

1.87

98.41

1.5

1.4

0.4

nmol/l

0.60

1128

4286

(3008898) HLA-B27 [Presence]

2599

11825

1.59

98.09

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1357

5145

1.90

97.83

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

44332

299977

1.28

97.19

18.4

12.6

40.0

40.3

8.32

33242

231800

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3236

15528

1.51

96.29

8.2

6.9

24.7

24.6

mmol/l

1.21

3058

14411

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1089

3859

2.03

95.29

2.0

1.8

5390.3

3375.0

titre

0.53

155

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1196

4397

1.95

94.40

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1642

6691

1.77

93.93

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1700

6998

1.75

93.92

1.3

—

(3008295) Osmolality of Serum or Plasma

777

2440

2.28

92.07

1.6

1.5

282.0

280.2

mosm/kgh2o

1.15

582

1951

(3010421) pH of Blood

1672

6896

1.75

91.74

4.4

3.6

7.4

8.36

1429

5820

(3022217) INR in Platelet poor plasma by Coagulation assay

5907

31929

1.35

90.70

18.4

21.0

1.2

1.3

inr

4.42

838

4788

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1553

6298

1.77

90.28

1.3

267.1

258.4

u/ml

0.56

1022

4049

(3035637) Corticotropin [Mass/volume] in Plasma

1011

3557

2.04

90.20

1.5

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2573

11913

1.56

89.92

1.4

1.3

222.2

224.1

miu/ml

0.09

1057

5808

(40768804) Tissue Pathology biopsy report

19718

123467

1.21

89.65

2.1

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4070

20732

1.43

89.02

2.6

2.2

7.0

7.5

ug/l

0.46

3453

18237

(3029634) Reagin Ab [Titer] in Serum by VDRL

1231

4673

1.89

88.38

2.4

2.1

10.1

5.9

titre

0.68

122

(3034770) Mitochondria Ab [Titer] in Serum

1933

8406

1.66

87.33

1.3

1.2

862.2

973.0

titre

0.24

243

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

454

1123

2.89

87.12

1.4

602.0

677.3

mu/l

0.27

426

1071

(3036489) Thrombin time

2454

11337

1.56

86.53

2.3

2.1

21.2

21.3

0.23

2111

9748

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

459

1148

2.86

86.37

1.4

73.0

72.7

0.15

431

1096

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

765

2453

2.23

86.34

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

1939

8481

1.65

85.64

4.8

4.1

1.4

mmol/l

0.23

1917

8328

(3027315) Oxygen [Partial pressure] in Blood

1473

5988

1.77

84.90

4.6

3.7

8.9

8.8

kpa

2.68

1438

5854

(3012501) Base excess in Blood by calculation

1464

5946

1.77

84.64

4.5

3.7

2.5

2.4

mmol/l

0.04

985

3979

(3013290) Carbon dioxide [Partial pressure] in Blood

1464

5948

1.77

84.54

4.5

3.7

5.1

5.0

kpa

5.45

1429

5815

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

778

2537

2.20

84.33

2.0

2.3

20.9

19.6

nmol/l

2.47

725

2426

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2105

9438

1.61

84.20

1.9

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

830

2790

2.13

83.44

1.1

—

(3020891) Body temperature

2174

9850

1.59

83.25

6.1

4.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2141

9677

1.60

82.81

1.9

1.7

38.8

40.3

nmol/l

1.76

2086

9490

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

780

2574

2.17

82.12

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

1332

5314

1.80

81.74

3.8

3.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2641

12559

1.52

81.63

1.7

1.6

3.8

3.4

mg/l

1.37

2048

8441

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1930

8543

1.63

81.28

1.3

25.6

37.7

u/ml

1.23

532

(3020630) Protein [Mass/volume] in Serum or Plasma

3906

20082

1.41

80.77

2.4

2.6

66.6

66.7

g/l

0.38

3554

18384

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

599

1786

2.40

79.79

1.4

1.3

5.3

5.2

umol/l

0.37

553

1650

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5470

29770

1.34

79.53

4.0

4.3

231.4

242.0

u/l

6.56

5130

28286

(3041096) Erythrocytes [Presence] in Urine by Automated

13805

84238

1.22

78.74

3.7

3.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

667

2101

2.27

78.53

3.2

3.3

29.4

26.8

mu/l

0.84

623

1979

(3023520) Reticulocytes [#/volume] in Blood

3922

20283

1.40

78.31

2.7

2.6

72.5

70.5

e9/l

2.41

2887

15223

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1527

6421

1.71

78.14

1.3

1.2

36.9

45.0

u/ml

1.15

142

638

(3016018) Differential panel - Cerebral spinal fluid

887

3149

2.02

77.24

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

758

2542

2.14

76.68

1.2

34.9

44.7

mg/l

5.73

628

2127

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1557

6635

1.69

75.86

2.1

1.9

190.6

198.4

pmol/l

1.88

1473

6352

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2301

10788

1.54

75.81

4.5

3.8

51.2

48.8

4.42

2275

10675

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

45751

312816

1.26

74.08

4.8

4.4

2.8

mmol/l

1.08

42565

292229

(3026389) Candida sp identified in Specimen by Organism specific culture

1125

4393

1.84

73.98

1.4

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

732

2459

2.13

73.75

1.1

231.9

267.8

mg/l

3.38

632

2171

(3021901) Oxygen saturation in Capillary blood

1139

4473

1.83

73.56

2.9

2.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

530

1556

2.43

73.03

1.1

3.4

5.2

nmol/l

0.40

316

(3037121) Protein [Mass/volume] in Urine

2015

9255

1.57

72.67

3.3

0.3

g/l

1.59

909

4106

(1002224) Polysomnography panel

2851

14097

1.46

72.57

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1527

6551

1.68

72.54

1.5

1.4

18.1

20.3

u/ml

0.29

136

(3043409) Potassium [Moles/volume] in Arterial blood

1668

7326

1.64

72.37

5.1

4.3

3.8

3.9

mmol/l

3.94

1563

6916

(3027273) Bicarbonate [Moles/volume] in Venous blood

2446

11746

1.50

72.00

4.2

3.3

25.4

25.3

mmol/l

1.09

2378

11363

(4027681)

617

1965

2.25

70.84

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1529

6608

1.66

70.62

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

497

1443

2.46

70.14

1.7

1.5

20.3

26.4

umol/l

4.95

472

1373

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

708

2396

2.11

70.02

1.1

—

(3017509) Phencyclidine [Presence] in Urine

205

346

4.22

69.38

2.3

1.6

—

(1761868) Lipid panel - Serum or Plasma

15254

122872

0.84

68.94

2.7

2.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1936

8927

1.56

68.60

2.8

2.6

178.7

183.2

1.32

1827

8460

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

662

2201

2.15

68.48

1.2

1.3

2.0

mmol/l

1.03

610

2049

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

11.34

68.14

1.4

424.9

587.0

nmol/l

1.00

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1422

6119

1.67

66.76

1.5

107.8

111.2

u/ml

0.48

294

1383

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

152

204

5.31

66.69

1.1

1.3

54.1

43.8

mg/l

1.40

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2476

12107

1.48

66.59

1.5

9.6

14.7

u/ml

1.75

347

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4981

27425

1.32

66.07

3.9

3.1

—

(40767503) Oxygen content in Capillary blood by calculation

1314

5566

1.69

65.43

2.9

2.4

17.0

16.7

1.77

702

2793

(3013005) Retinol [Moles/volume] in Serum or Plasma

435

1228

2.53

65.11

2.0

1.8

2.0

1.9

umol/l

0.60

410

1150

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

45102

308724

1.24

65.07

4.4

4.0

4.7

mmol/l

25.77

42213

290172

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

658

2250

2.09

63.40

1.1

294.5

420.3

mg/l

0.47

586

2029

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6819

59131

0.79

63.37

3.7

21.6

21.7

0.21

2561

25458

(3028271) Lactate [Moles/volume] in Capillary blood

1036

4139

1.79

63.28

2.2

1.8

1.7

mmol/l

1.25

1014

4038

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1417

6183

1.65

63.05

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1851

8625

1.54

62.55

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2052

9782

1.51

62.42

2.6

2.3

94.8

93.0

2.64

1910

9081

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1722

7917

1.56

61.75

1.3

8.9

9.4

u/ml

0.09

242

1245

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1418

6224

1.64

61.64

1.7

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2262

11049

1.47

61.07

2.2

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1166

4887

1.71

60.35

1.6

0.7

0.8

g/l

2.13

900

3669

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2520

12598

1.44

60.31

2.0

39.7

u/l

0.01

2288

11353

(3034274) Bile acid [Moles/volume] in Serum --fasting

1193

5033

1.70

60.29

2.0

2.2

5.7

6.7

umol/l

1.53

875

3679

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1999

9556

1.51

59.98

1.7

1.6

233.4

308.8

titre

0.57

384

(3017732) Neutrophils [#/volume] in Blood

3942

21262

1.34

59.95

3.1

2.6

4.2

4.1

e9/l

1.85

3048

16999

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

44756

306697

1.22

59.21

4.3

4.0

1.4

1.5

mmol/l

167.83

41722

287274

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

999

4037

1.77

58.75

1.3

0.2

nmol/l

1.00

240

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1377

6073

1.63

58.73

6.9

5.8

1132.6

1789.8

iu/ml

0.37

181

899

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1370

6040

1.63

58.51

1.8

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1002

4059

1.77

58.44

1.3

1.8

1.2

nmol/l

0.27

964

3910

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1685

7809

1.55

58.31

1.3

8.3

6.3

u/ml

0.39

157

816

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1911

9107

1.51

58.18

3.2

2.7

3.5

3.6

g/l

1.39

1811

8695

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3869

35668

0.75

57.97

1.6

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1959

9407

1.50

57.50

1.5

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

830

3195

1.86

57.16

1.4

1.3

23.3

31.0

nmol/l

0.73

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1950

9378

1.50

56.81

2.2

2.0

2.1

2.3

ug/l

0.27

1727

8308

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

599

2062

2.08

56.77

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

596

2050

2.08

56.61

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2056

10035

1.47

55.66

2.1

1.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

390

1131

2.46

55.30

2.1

1.9

28.2

29.0

umol/l

0.75

378

1089

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1740

8216

1.52

55.30

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4856

43195

0.78

55.10

2.6

2.7

0.6

0.7

ug/l

18.06

3105

25648

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

516

1704

2.16

54.40

1.1

1.0

1.1

u/l

0.72

226

763

(43055514) Macroprolactin [Presence] in Serum or Plasma

325

870

2.67

54.15

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

12229

75990

1.19

53.06

2.6

2.5

2149.3

3820.8

umol/l

8.79

10588

67072

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2704

14000

1.39

52.99

10.2

10.0

—

(3016038) Potassium [Moles/volume] in Urine

472

1524

2.21

52.59

1.4

1.3

33.1

33.7

mmol/l

0.18

409

1314

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

43232

296000

1.19

52.51

3.9

3.6

1.4

1.3

mmol/l

107.37

40033

276119

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

898

3645

1.76

52.06

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1390

6342

1.57

51.50

1.3

1.2

2.5

6.3

u/ml

2.10

474

(3004588) Protein electrophoresis panel - Serum or Plasma

3064

16263

1.36

51.49

2.2

2.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

351

1014

2.47

50.23

1.5

1.4

13.9

15.0

pmol/l

2.95

281

873

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1365

6243

1.57

50.05

1.2

20.4

14.7

u/ml

0.19

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

594

2137

1.99

50.01

2.8

2.6

814.5

741.4

e6/l

0.55

222

863

(3022806) Fractional oxyhemoglobin in Capillary blood

844

3405

1.77

49.97

2.2

1.7

90.4

90.1

0.81

829

3348

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1063

4576

1.66

49.86

3.4

2.9

562.7

7296.6

u/ml

1.40

246

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1930

9509

1.46

49.75

1.1

4.9

5.2

u/ml

0.10

205

1378

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1638

7812

1.51

49.64

1.9

15.2

18.6

iu/l

0.12

571

2993

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

487

1632

2.13

49.54

1.4

1.5

5.6

5.9

u/l

0.26

412

1379

(3021367) Citalopram [Moles/volume] in Serum or Plasma

14.49

49.53

1.3

1.6

137.6

140.3

nmol/l

0.03

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

384

1170

2.34

48.99

2.7

2.4

52.3

54.1

umol/l

0.51

324

980

(21494815) CD4 cells/100 lymphocytes in Specimen

681

2590

1.88

48.74

2.5

2.2

43.2

41.2

0.56

340

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1617

7722

1.50

48.69

1.3

1.5

9.0

14.6

iu/ml

1.70

195

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1025

4418

1.66

47.85

1.8

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

716

2784

1.84

47.85

1.7

—

(3003338) MCHC [Mass/volume]

40952

279706

1.17

47.49

22.3

14.8

332.9

g/l

0.47

40694

277648

(3011412) CD3 cells [#/volume] in Blood

734

2885

1.82

47.39

2.6

2.4

1.3

1.1

e9/l

4.71

443

1718

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6334

37317

1.23

47.33

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2635

13836

1.37

47.31

2.4

2.3

—

(3025130) Human papilloma virus identified in Specimen

1111

4907

1.62

47.14

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9029

74191

0.84

46.76

4.1

4.3

2.6

ug/l

0.07

8046

67662

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

453

1518

2.13

46.13

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

443

1472

2.15

46.08

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5804

33972

1.24

45.98

4.2

30.7

32.2

20.81

4215

23943

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

812

3325

1.75

45.72

7.2

6.2

11.0

11.3

mg/l

0.92

739

3066

(3006922) Hepatitis E virus Ab [Presence] in Serum

590

2187

1.93

45.65

1.1

—

(40761536) Microorganisms panel - Urine sediment

4571

26076

1.27

45.27

4.6

3.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1313

6116

1.54

44.41

2.3

2.1

133.2

131.3

g/l

1.92

975

4483

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

333

998

2.38

44.13

1.2

110.4

111.2

0.19

300

891

(3001186) Copper [Moles/volume] in Serum or Plasma

261

700

2.66

43.45

1.4

1.3

17.0

16.8

umol/l

0.23

229

624

(3025468) Yersinia sp identified in Specimen by Organism specific culture

840

3527

1.70

43.29

1.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1101

4959

1.59

43.12

1.3

1.2

3.8

u/ml

0.02

505

2230

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

840

3531

1.70

43.11

1.5

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

762

3118

1.75

43.04

1.5

1.3

6.5

6.7

g/l

0.86

557

2139

(3024139) IgG subclass 3 [Mass/volume] in Serum

761

3114

1.75

42.98

1.5

1.3

0.4

g/l

2.26

560

2141

(3005988) Vibrio sp identified in Specimen by Organism specific culture

840

3534

1.70

42.98

1.5

1.4

—

(4062490)

763

3126

1.75

42.91

1.5

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

761

3116

1.75

42.89

1.5

1.3

2.9

g/l

0.37

553

2143

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2274

11844

1.38

42.86

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1616

7932

1.46

42.45

1.9

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

349

1088

2.29

42.36

1.2

0.3

g/l

0.19

276

861

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

844

3573

1.69

42.21

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

860

3661

1.68

42.13

1.5

1.4

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

9.28

42.08

1.6

1.5

301.4

178.9

nmol/l

1.04

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1124

5129

1.57

41.66

1.3

1.2

3.7

u/ml

0.02

378

1776

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2163

11243

1.38

41.26

1.8

1.5

g/l

0.18

1869

9655

(3024522) Salmonella sp identified in Specimen by Organism specific culture

840

3582

1.68

40.90

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1020

4574

1.60

40.71

1.6

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3609

20253

1.29

40.63

3.0

2.7

142.8

176.4

ng/l

5.28

3210

18297

(3036180) Methadone [Presence] in Urine

9.72

40.48

2.5

3.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

537

2010

1.91

40.43

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

551

2086

1.89

40.10

1.2

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

1002

4491

1.60

40.09

4.2

3.3

64.3

65.5

0.94

996

4475

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

782

3290

1.70

40.04

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

244

660

2.63

40.01

1.4

1.2

131.9

132.0

nmol/l

0.01

175

497

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1435

6965

1.48

39.92

2.2

0.0

g/l

1.24

1313

6381

(3047181) Lactate [Moles/volume] in Blood

1673

8366

1.43

39.83

6.3

5.5

1.3

mmol/l

0.96

1475

7380

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

240

646

2.65

39.74

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

537

2022

1.90

39.73

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

10.19

39.47

1.7

1.5

334.8

231.6

nmol/l

0.45

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1726

8698

1.42

39.39

2.2

2.3

3.0

3.1

g/l

4.13

1361

6768

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

507

1879

1.93

39.33

2.2

2.1

100.6

97.1

1.30

473

1743

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1050

4783

1.57

39.23

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1574

7810

1.45

39.07

2.3

2.4

0.6

0.8

g/l

2.00

1380

6751

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

351

1147

2.18

38.16

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

604

2395

1.80

38.00

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1451

7128

1.46

37.97

2.1

2.2

38.8

37.9

g/l

6.85

1270

6153

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

604

2397

1.80

37.90

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1801

9210

1.40

37.82

2.1

2.2

7.1

7.4

g/l

5.87

1393

6917

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

479

1765

1.94

37.81

1.4

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

604

2401

1.80

37.70

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

598

2370

1.80

37.69

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

250

706

2.52

37.66

1.2

1.3

93.6

92.5

0.22

244

696

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1327

6421

1.48

37.50

2.2

2.3

0.0

g/l

0.12

1210

5854

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1797

9200

1.40

37.49

2.1

2.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

598

2374

1.80

37.49

1.2

—

(3012516) Albumin [Mass/volume] in Urine

12308

78244

1.15

37.47

3.4

3.3

504.2

418.9

mg/l

0.98

7869

49065

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

630

2541

1.77

37.46

1.7

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

551

2135

1.84

37.36

2.2

2.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

598

2377

1.80

37.34

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

914

4077

1.60

37.33

1.1

1.5

g/l

0.02

823

3701

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1793

9187

1.40

37.23

2.1

2.2

3.7

3.8

g/l

2.25

1338

6571

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

192

476

2.87

37.05

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

811

3520

1.65

36.96

1.7

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

875

3878

1.61

36.70

1.3

1.2

58.8

51.9

u/ml

0.25

258

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1308

6341

1.48

36.62

2.2

2.3

0.0

g/l

0.00

1209

5834

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1685

8568

1.41

36.56

2.1

2.2

9.9

10.2

g/l

2.30

1427

7189

(3012920) Ethanol [Mass/volume] in Serum or Plasma

9.88

36.53

1.7

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

455

1668

1.95

36.48

1.3

1.5

6.1

8.3

ug/l

3.49

416

1499

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

246

701

2.50

36.40

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2648

24163

0.77

35.81

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

582

2326

1.79

35.71

2.2

2.1

74.7

73.0

2.09

563

2237

(3051651) Icteric interference index of Serum or Plasma

434

1578

1.96

35.64

4.1

3.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1981

10395

1.37

35.62

5.6

4.9

1.9

1.7

8.77

1861

9710

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

599

2418

1.77

35.55

1.2

1.1

65.6

66.1

u/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1032

4796

1.54

35.34

1.1

120.0

118.4

0.80

936

4347

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.61

35.27

2.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

690

2906

1.70

35.26

7.0

7.8

7.1

7.3

mmol/l

0.45

562

2370

(3017315) Amylase [Enzymatic activity/volume] in Urine

418

1507

1.98

35.17

1.3

1.2

258.1

337.4

u/l

1.01

391

1412

(3007930) Methemoglobin/Hemoglobin.total in Blood

1943

10188

1.37

35.10

5.7

5.0

0.9

0.23

1828

9521

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

12.45

35.06

3.0

2.5

2.6

2.1

ug/l

0.49

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2578

14119

1.31

34.75

3.0

2.5

0.3

e6/l

0.39

2495

13689

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1052

4928

1.53

34.74

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

444

5748

0.55

34.73

1.5

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

548

2170

1.80

34.69

1.4

11.1

11.9

umol/l

2.30

508

2077

(3020682) Albumin/Creatinine [Ratio] in Urine

12823

82126

1.14

34.55

4.1

4.0

9.8

9.0

mg/mmol

0.88

8120

51837

(4306422)

1062

4991

1.52

34.55

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1479

7426

1.43

34.45

1.1

1.6

1.8

u/ml

0.20

663

2992

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

539

2129

1.81

34.40

2.7

2.6

544.0

527.9

e6/l

0.25

459

1763

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

554

2209

1.79

34.28

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

944

4330

1.56

34.28

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1589

8089

1.41

34.26

2.0

2.1

10.8

10.7

mg/l

0.08

1476

7591

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

570

2296

1.77

34.10

2.2

2.1

11.9

14.0

3.80

287

1119

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

738

3211

1.64

33.36

2.1

1.9

22.0

26.1

mg/l

1.16

199

849

(3026250) Tacrolimus [Mass/volume] in Blood

388

1389

1.99

33.33

40.3

35.8

7.4

ug/l

0.01

358

1274

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

862

3903

1.58

33.12

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1344

6687

1.44

32.91

1.1

5.9

u/ml

0.01

758

3441

(3023420) DNA double strand Ab [Units/volume] in Serum

776

3432

1.62

32.88

1.6

36.5

33.9

iu/ml

0.16

157

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

522

2071

1.80

32.87

2.8

2.6

0.2

e9/l

0.68

456

1770

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

296

962

2.19

32.71

3.0

2.9

29.6

28.3

umol/l

0.78

217

736

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1052

4994

1.51

32.67

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

748

3284

1.63

32.64

1.5

1.4

—

(3001556) Androgen free Index in Serum or Plasma

150

349

3.06

32.35

1.3

—

(44790049)

698

3026

1.65

32.03

1.7

1.6

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

12.06

32.01

1.3

173.9

181.2

nmol/l

0.06

(44806118)

698

3027

1.65

31.99

1.7

1.6

—

(44790047)

698

3027

1.65

31.99

1.7

1.6

—

(44790048)

698

3028

1.65

31.95

1.7

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

281

906

2.21

31.68

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

808

3645

1.58

31.56

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

848

3873

1.57

31.41

1.5

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

404

1499

1.92

31.36

1.3

61.0

65.3

0.31

180

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

408

1523

1.91

31.12

2.2

1.8

140.5

137.4

0.31

385

1436

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

394

1455

1.93

31.02

1.6

—

(44813793)

573

2380

1.72

30.87

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1014

4835

1.50

30.85

1.1

815.6

2678.2

iu/ml

0.42

241

1135

(3045414) Leukocytes [Presence] in Urine

2410

13302

1.30

30.64

1.9

1.8

—

(3045716) Anion gap in Serum or Plasma

314

1077

2.08

30.34

2.6

2.4

9.1

9.2

mmol/l

0.21

231

789

(3010503) CD19 cells [#/volume] in Blood

443

1715

1.84

30.24

2.8

2.6

0.3

e9/l

0.10

430

1674

(3011985) Renin [Units/volume] in Plasma

868

4023

1.54

30.15

1.6

71.6

62.4

mu/l

0.54

767

3620

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

534

2189

1.74

30.15

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

534

2189

1.74

30.15

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

534

2189

1.74

30.15

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1001

4795

1.49

29.80

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

466

1844

1.80

29.66

2.7

3.3

110.4

124.6

nmol/l

0.47

457

1810

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1159

5730

1.45

29.40

3.1

2.1

0.9

0.8

nmol/l

3.80

965

4836

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

557

2332

1.70

29.19

2.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

284

952

2.13

29.14

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

110

228

3.43

28.49

4.0

3.7

2.3

mg/l

0.08

197

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1260

6363

1.42

28.48

1.1

1.3

1.1

u/ml

0.30

574

2692

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

391

1484

1.88

28.42

1.1

7.5

10.9

u/ml

1.12

266

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1068

5246

1.46

28.05

1.1

15.1

11.7

au/ml

0.41

379

(3000492) Spirometry study

5252

31857

1.19

28.04

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3910

23085

1.22

27.80

2.8

2.5

73.2

68.8

ml/min/173m2

7.56

1544

8768

(3010015) Selenium [Moles/volume] in Serum or Plasma

110

232

3.37

27.77

2.2

2.1

1.3

umol/l

0.17

208

(3014148) Varicella zoster virus Ab [Titer] in Serum

961

4634

1.48

27.73

1.2

—

(40768443) Skin Pathology biopsy report

2282

12672

1.29

27.70

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

353

1311

1.92

27.41

2.2

2.1

16.3

24.9

umol/l

1.06

128

(3051611) Lipemic interference index of Serum or Plasma

630

2774

1.62

27.27

3.8

3.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

266

897

2.11

26.93

1.2

14.8

21.5

0.63

163

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1103

5494

1.44

26.92

1.3

3.4

3.7

ug/l

0.83

992

4949

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

230

733

2.24

26.76

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1562

8266

1.35

26.64

2.7

2.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1237

6309

1.40

26.45

1.1

2.3

u/ml

0.03

333

1577

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

220

693

2.26

26.32

3.1

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

220

693

2.26

26.32

3.1

2.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

220

694

2.26

26.23

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

563

2440

1.65

25.98

1.4

1.3

1.5

1.4

nmol/l

1.72

516

2198

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

280

979

2.04

25.81

2.5

2.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

180

523

2.45

25.76

1.1

1.2

9.3

6.7

u/ml

0.15

118

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

298

1067

1.99

25.74

2.1

2.5

1.1

ug/l

0.13

283

997

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

790

3719

1.52

25.63

1.4

348.1

304.3

pmol/l

1.66

621

2914

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

646

2909

1.59

25.53

1.8

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

366

1409

1.85

25.53

1.5

1.6

16.7

5.5

nmol/l

0.35

296

1174

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

256

869

2.10

25.52

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

754

3520

1.53

25.43

1.1

95.2

96.2

0.39

704

3312

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

766

3593

1.52

25.28

1.6

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

123

296

2.96

25.18

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

151

3.86

25.13

1.4

84.8

73.9

umol/l

1.35

136

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

298

1078

1.97

25.03

1.1

93.5

91.6

0.49

137

496

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1074

5398

1.42

24.98

1.3

1.2

57.4

153.1

titre

2.64

108

(3019977) pH of Arterial blood

342

1298

1.88

24.94

2.8

2.4

7.4

1.27

472

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

416

1684

1.76

24.65

2.9

2.7

40.4

39.3

0.38

126

591

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1505

8016

1.34

24.62

5.4

3.7

1.5

1.4

mg/l

1.14

1397

7455

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1829

10019

1.31

24.60

1.7

1.6

3.3

6.6

iu/ml

0.44

387

2039

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

217

700

2.21

24.58

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

217

702

2.20

24.41

1.1

6.1

7.2

mg/g

1.43

202

672

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

152

419

2.58

24.26

2.1

2.5

1.2

mmol/l

0.28

147

397

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

564

2491

1.62

24.18

1.2

155.6

206.4

titre

0.84

410

(4268621)

730

3426

1.52

24.06

2.4

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

562

2484

1.61

24.03

1.2

87.1

210.7

titre

2.12

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

290

1055

1.96

23.99

1.1

95.1

93.0

0.37

135

491

(3004616) Nuclear Ab [Presence] in Serum

770

3658

1.50

23.96

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

440

1831

1.71

23.69

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1976

11009

1.29

23.39

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1975

11003

1.29

23.38

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

974

4869

1.43

23.37

1.3

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

212

692

2.18

23.37

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

526

2304

1.63

23.34

1.3

0.6

1.3

u/ml

2.24

233

975

(3003694) ABO and Rh group [Type] in Blood

14198

93231

1.11

23.33

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

214

703

2.17

23.22

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

298

1108

1.92

23.17

1.2

1.1

112.2

109.0

0.64

273

997

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

649

2994

1.55

23.15

1.2

66.5

65.2

u/l

0.10

451

2030

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1964

10953

1.28

23.07

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1969

10985

1.28

23.06

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

489

2111

1.65

22.98

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1047

5323

1.41

22.86

3.6

3.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

202

653

2.20

22.81

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2085

11746

1.27

22.58

1.4

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

212

706

2.14

22.27

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

186

588

2.25

22.16

1.1

2.6

7.8

u/ml

1.32

133

408

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

400

1653

1.73

22.12

2.4

2.5

723.1

1025.9

u/ml

2.83

395

1636

(3029075) Extractable nuclear Ab panel - Serum

249

887

2.00

21.91

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

523

2335

1.60

21.52

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

285

1072

1.89

21.45

2.1

2.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

317

1235

1.83

21.40

2.4

2.3

10.5

10.3

0.08

301

1147

(3008757) Leukocyte morphology finding [Identifier] in Blood

606

2805

1.54

21.34

3.5

3.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

341

1360

1.79

21.33

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

253

916

1.97

21.29

2.4

2.2

191.2

366.2

e6/l

1.07

163

478

(3034988) Calcium [Moles/volume] in Capillary blood

154

456

2.40

21.28

2.5

2.4

1.2

mmol/l

0.87

149

432

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

173

548

2.25

20.56

1.5

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

307

1204

1.82

20.32

1.5

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

648

3077

1.50

20.30

2.8

3.3

6.0

7.3

nmol/l

0.27

620

2985

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

292

1131

1.84

20.12

2.2

1.9

152.4

162.3

0.86

281

1063

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

306

1204

1.81

20.05

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

292

1133

1.84

20.01

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

878

4439

1.41

19.86

1.5

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

263

991

1.89

19.74

1.1

1.7

17.9

u/ml

0.95

161

553

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

115

307

2.67

19.64

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

267

2.80

19.63

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1639

9120

1.29

19.63

1.4

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

116

313

2.64

19.42

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

304

1208

1.79

19.31

2.3

2.2

28.9

29.3

0.19

293

1144

(3004809) Band form neutrophils/100 leukocytes in Blood

845

4276

1.41

19.04

3.0

3.2

1.3

1.5

0.52

664

3300

(3028433) Virus identified in Specimen by Culture

249

934

1.90

18.97

1.2

—

(3022621) pH of Urine by Test strip

3180

19092

1.20

18.82

3.1

2.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

461

2066

1.59

18.76

1.1

ratio

0.04

142

747

(3050129) First trimester maternal screen panel - Serum or Plasma

2417

14138

1.23

18.74

1.5

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

612

2935

1.49

18.33

3.9

4.8

81.5

110.1

u/ml

0.57

166

926

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2863

17065

1.20

18.33

3.1

3.2

51.0

47.6

u/ml

0.12

2749

16502

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

164

534

2.19

18.32

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

787

3963

1.42

18.25

2.5

2.9

1318.9

315.7

u/ml

0.39

740

3765

(3014051) Protein [Presence] in Urine by Test strip

1201

6489

1.32

17.93

2.1

—

(3005033) Fetal Nuchal fold Thickness US

1588

8913

1.27

17.78

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

423

1882

1.60

17.77

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

281

1122

1.78

17.62

3.1

2.8

—

(3016228) CD19 cells/100 cells in Blood

286

1149

1.77

17.57

2.1

2.0

8.7

8.5

0.14

278

1124

(40768800) Prostate Pathology biopsy report

362

4118

0.62

17.41

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

465

2127

1.56

17.38

3.0

2.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

328

1376

1.70

17.33

2.3

2.2

20.8

162.5

ug/l

1.90

313

1314

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

320

1335

1.71

17.25

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

320

1335

1.71

17.25

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

320

1335

1.71

17.25

2.0

1.9

—

(3032057) Clostridioides difficile [Presence] in Stool

155

506

2.18

17.24

1.9

1.8

—

(3017569) Oxygen content in Arterial blood

267

1057

1.80

17.24

2.0

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6210

39483

1.13

17.18

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1585

8934

1.27

17.16

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

323

1355

1.70

17.07

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

320

1340

1.70

17.03

2.0

1.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1039

5541

1.34

16.99

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

494

2303

1.53

16.97

4.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

163

547

2.12

16.94

1.6

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

359

1553

1.65

16.91

1.0

256.5

342.9

ng/l

2.95

273

1111

(21494814) CD8 cells/100 lymphocytes in Specimen

279

1126

1.77

16.90

2.1

2.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

361

1567

1.64

16.78

1.0

35.0

42.3

ng/l

2.59

272

1095

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

285

1160

1.75

16.78

1.1

136.9

604.7

ng/l

1.91

265

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

360

1565

1.64

16.64

1.0

845.9

738.6

ng/l

3.95

266

1075

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

163

551

2.11

16.64

1.3

1.5

5.7

5.6

nmol/l

0.14

154

527

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

458

2113

1.55

16.51

1.1

6.9

8.2

iu/ml

0.60

574

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

375

1652

1.62

16.45

1.2

21.9

23.4

u/l

0.23

322

1428

(3023419) Bacteria identified in Sputum by Culture

630

3109

1.45

16.38

2.7

2.5

—

(3039000) Anion gap in Blood

1077

5806

1.32

16.37

7.8

6.6

11.2

mmol/l

0.07

978

5210

(3018572) Chloride [Moles/volume] in Blood

1077

5807

1.32

16.35

7.8

6.6

105.1

105.2

mmol/l

0.35

978

5212

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

368

1618

1.62

16.28

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

257

2.63

15.92

1.6

1.4

1.9

mg/l

0.48

169

(3027923) C peptide [Moles/volume] in Serum or Plasma

350

1529

1.63

15.90

1.6

1.7

1.2

1.3

nmol/l

0.24

256

1235

(3041806) Other cells [#/volume] in Blood by Manual count

366

1618

1.61

15.86

1.5

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

317

1351

1.67

15.85

28.2

27.2

126.9

117.4

ug/l

0.75

259

1121

(3042733) HLA Ab [Presence] in Serum

270

1101

1.75

15.83

4.3

5.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

260

1049

1.77

15.81

2.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

381

1703

1.59

15.78

1.2

92.1

87.5

u/l

0.30

334

1495

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1014

5452

1.33

15.72

1.1

4.3

4.6

u/ml

0.20

423

2161

(3014271) Vancomycin [Susceptibility]

259

1046

1.76

15.70

3.2

2.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

192

706

1.94

15.62

1.3

1.2

108.6

107.7

0.13

183

665

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

158

542

2.08

15.57

1.4

1.5

0.3

0.2

nmol/l

0.42

116

398

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

230

901

1.82

15.43

3.4

3.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

255

1031

1.76

15.41

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

255

1031

1.76

15.41

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

526

2.08

15.35

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

425

1963

1.54

15.29

1.6

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

101

288

2.50

15.26

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

359

1595

1.60

15.26

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

340

1491

1.62

15.24

9.4

5.5

593.5

3628.3

u/ml

0.69

117

273

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

1.0

1.5

mg/l

0.70

155

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

2.7

2.3

mg/l

0.27

175

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

2.9

mg/l

0.00

183

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

0.9

mg/l

0.07

168

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

2.2

mg/l

0.47

185

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

1.9

2.2

mg/l

0.16

166

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

1.8

mg/l

0.32

177

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

2.3

1.7

mg/l

0.48

153

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

251

2.61

15.19

1.6

3.2

4.3

mg/l

0.90

162

(3049717) Cytology report of Urine Cyto stain

1496

8502

1.26

15.15

2.3

2.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

138

454

2.16

15.13

1.1

1.0

85.9

80.4

ug/l

0.72

118

373

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

143

478

2.13

15.07

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

467

2209

1.51

15.06

1.2

1.1

381.0

381.8

nmol/l

0.03

411

1916

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

116

356

2.32

14.98

1.3

50.8

53.1

0.17

179

(3024869) Neuronal Ab [Presence] in Serum

134

438

2.18

14.94

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1440

8164

1.26

14.90

3.9

3.2

0.3

0.4

u/ml

2.04

838

4599

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

184

679

1.93

14.85

1.1

1.2

89.3

87.9

0.13

185

(3035947) Staphylolysin Ab [Units/volume] in Serum

319

1387

1.64

14.81

1.2

1.1

3.5

3.8

iu/ml

0.28

107

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

384

1752

1.56

14.62

1.7

1.6

4.0

6.8

u/l

4.00

181

870

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

106

316

2.39

14.61

1.0

0.8

2.1

u/ml

0.74

234

(3045462) Protein/Creatinine [Ratio] in Urine

289

2.44

14.28

5.1

5.3

59.3

51.8

g/mol

0.12

259

(3033923) Metanephrine [Moles/time] in 24 hour Urine

161

576

1.99

14.22

1.1

0.7

3.2

umol/24h

0.53

296

(3027231) Wheat IgE Ab [Units/volume] in Serum

183

685

1.90

14.19

1.1

1.0

1.3

2.1

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3484

21567

1.16

14.17

1.5

—

(3002256) Pathology report gross observation

6006

38534

1.12

14.14

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1021

5580

1.31

14.14

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

220

876

1.79

14.05

2.1

1.9

—

(3038026) Centromere Ab [Units/volume] in Serum

485

2352

1.47

13.89

1.3

1.2

59.4

48.5

u/ml

0.24

107

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

402

1876

1.53

13.86

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.70

13.75

5.7

4.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

943

5120

1.31

13.72

1.1

6.7

4.9

u/ml

1.04

423

2140

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

154

551

1.99

13.62

6.2

5.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

221

891

1.77

13.56

1.8

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

525

2602

1.44

13.45

3.0

3.2

58.0

58.1

0.05

343

1671

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

137

473

2.06

13.35

1.6

1.3

759.4

99.8

ng/l

0.44

316

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

342

1555

1.57

13.27

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

378

1760

1.53

13.20

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

237

983

1.72

13.19

2.1

1.6

46454.3

22767.4

u/ml

0.26

106

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

104

3.42

13.12

4.2

2.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

471

2301

1.46

13.03

1.3

1.2

63.8

42.7

u/ml

0.88

180

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

470

2296

1.46

13.01

1.3

1.2

68.0

67.7

u/ml

0.01

110

(3000475) Leukocytes [#/volume] in Synovial fluid

1171

6588

1.27

12.98

1.7

1.6

14388.0

12382.1

e6/l

0.61

827

4838

(3042631) Mycobacterium sp identified in Specimen

634

3273

1.38

12.89

2.8

2.6

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

222

2.56

12.85

1.2

18.8

14.7

nmol/l

0.80

(3022493) Free Hemoglobin [Mass/volume] in Plasma

276

1202

1.64

12.82

5.2

5.4

67.4

3502.5

mg/l

5.35

204

858

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

151

2.92

12.68

1.2

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

103

324

2.26

12.66

1.0

1.5

1.3

u/ml

0.06

240

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

256

1099

1.66

12.58

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

100

3.41

12.58

3.9

2.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

177

683

1.84

12.57

1.1

72.2

76.9

0.51

175

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

293

1307

1.60

12.37

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

100

314

2.27

12.36

2.5

3.4

42.4

umol/l

0.01

264

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

214

2.56

12.35

1.4

6.7

14.8

pmol/l

2.14

181

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

341

1577

1.54

12.32

1.1

1662.9

1472.5

miu/ml

2.19

341

1577

(3024932) HLA-DR beta [Type]

249

1068

1.66

12.29

1.1

—

(3024471) HLA-A [Type]

253

1090

1.65

12.28

1.0

—

(40768441) Liver Pathology biopsy report

442

2167

1.45

12.05

1.5

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.92

12.05

1.2

1.0

—

mmol/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

301

1361

1.58

12.02

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

448

2206

1.45

11.95

1.3

1.2

13.4

9.4

u/ml

0.27

153

(3000093) Morphology [Interpretation] in Blood Narrative

500

2521

1.41

11.73

1.2

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

340

1592

1.52

11.64

1.2

10.9

13.6

u/ml

0.17

154

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

108

360

2.13

11.59

1.3

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1249

7184

1.24

11.49

3.2

3.3

1.5

3.7

ratio

1.41

117

548

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

157

601

1.86

11.48

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

250

1094

1.63

11.45

1.1

1.0

7.5

12.3

u/ml

1.48

145

(3034860) Kappa light chains.free [Mass/volume] in Serum

1283

7408

1.24

11.39

3.3

3.4

46.5

63.6

mg/l

0.93

1039

5984

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

127

454

1.99

11.35

1.1

0.2

0.3

u/ml

0.21

281

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

324

1511

1.53

11.32

1.1

97.6

97.4

0.03

260

1203

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1280

7397

1.24

11.28

3.3

3.4

30.9

43.1

mg/l

4.18

1029

5981

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

958

5354

1.28

11.28

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

878

4858

1.29

11.20

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

125

447

1.99

11.17

2.3

2.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

576

5505

0.74

11.03

3.4

2.4

13.2

13.1

0.63

571

5434

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.76

10.86

1.0

0.4

0.6

u/ml

0.40

(40761539) Cells [Type] in Urine sediment by Light microscopy

171

687

1.77

10.74

1.2

—

(3002619) Bacteria identified in Specimen by Culture

146

559

1.86

10.71

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

429

2142

1.43

10.68

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

201

2.48

10.58

1.0

0.2

2.2

u/ml

1.76

158

(3003721) Smooth muscle Ab [Units/volume] in Serum

206

2.45

10.51

1.1

1.6

3.1

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

119

428

1.98

10.50

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

164

657

1.78

10.42

1.3

1.2

403.4

319.5

pmol/l

0.78

114

488

(3044941) Cell count panel - Synovial fluid

773

4252

1.30

10.35

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

236

1047

1.60

10.29

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

294

1376

1.52

10.17

1.2

1.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

163

2.62

10.14

1.7

1.6

198.7

165.9

ug/g

0.60

143

(3000330) Specific gravity of Urine by Test strip

2188

13419

1.17

10.11

3.5

3.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

314

1494

1.50

10.05

1.4

1.3

457.5

442.1

titre

0.02

(3013336) Amino acids [Identifier] in Serum or Plasma

3.78

10.05

2.2

2.9

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

120

440

1.94

10.05

1.7

1.8

72.8

50.8

pmol/l

0.27

104

373

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

681

3702

1.31

9.97

1.2

1.1

2.0

2.1

iu/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

302

1430

1.50

9.90

3.5

3.2

7.9

8.2

mg/l

0.34

250

1140

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

306

1453

1.50

9.90

1.4

1.3

62.6

79.6

titre

0.40

118

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

244

2.27

9.82

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

794

4415

1.28

9.81

1.1

1.0

0.4

0.5

u/ml

0.50

185

921

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

166

2.57

9.81

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

912

5159

1.26

9.79

1.1

2.8

u/ml

0.05

351

2679

(4034850)

1575

9429

1.19

9.75

11.1

8.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

629

1.76

9.74

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

132

506

1.86

9.70

2.5

2.7

31.6

47.9

mg/l

0.65

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

297

2.13

9.62

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

228

1023

1.59

9.53

2.7

2.2

—

(37021550) Renin [Units/volume] in Plasma --upright

145

576

1.79

9.52

1.4

1.3

107.0

73.2

mu/l

0.31

114

429

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

303

2.11

9.52

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

136

530

1.83

9.50

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

248

2.24

9.48

2.2

—

(4024509)

488

2549

1.36

9.39

1.7

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

196

2.39

9.35

3.9

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

292

2.12

9.28

1.2

—

(3034426) Prothrombin time (PT)

244

1120

1.55

9.27

1.3

1.2

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.56

9.25

1.1

298.5

417.8

pmol/l

0.50

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

167

2.51

9.24

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

924

5277

1.25

9.17

3.4

3.0

1.5

mmol/l

0.70

906

5157

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

298

1433

1.48

9.11

1.2

1.1

34.2

22.9

u/l

1.02

222

1119

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

298

1433

1.48

9.11

1.2

1.1

96.9

82.9

u/l

1.10

237

1153

(3006442) Creatine [Moles/volume] in Serum or Plasma

415

2123

1.39

9.09

1.8

1.4

60.4

71.8

umol/l

3.46

185

(3021788) Differential panel - Synovial fluid

895

5099

1.25

9.08

1.6

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

596

3225

1.32

9.08

1.1

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

276

1308

1.50

9.06

2.9

2.7

135.0

155.8

au/ml

0.31

176

(3044927) Protein electrophoresis panel - Urine

432

2226

1.38

9.06

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

174

2.45

8.95

1.5

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

197

867

1.62

8.95

5.8

6.4

25.1

mmol/l

0.07

184

790

(3020123) Porphyrins [Interpretation] in Serum or Plasma

170

2.47

8.92

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1222

7210

1.21

8.89

1.3

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

327

1611

1.45

8.85

1.5

1.4

11.8

12.5

u/l

1.05

317

1560

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

395

1.93

8.85

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

197

2.35

8.83

1.5

34.7

38.0

0.24

134

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

193

2.36

8.80

1.0

0.3

0.7

u/ml

1.04

177

(44806071)

111

417

1.89

8.73

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

101

368

1.95

8.68

1.0

0.1

0.2

u/ml

1.00

220

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1225

7248

1.21

8.66

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1286

7653

1.20

8.56

1.5

1.4

122.5

123.3

pmol/l

0.02

1252

7462

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

108

405

1.90

8.55

2.4

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

187

2.36

8.53

2.1

1.7

49.3

46.2

umol/l

0.26

187

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1970

12150

1.16

8.51

1.5

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

215

2.25

8.42

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

964

5586

1.23

8.41

3.3

3.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

339

1702

1.42

8.32

1.5

24.9

23.4

u/ml

0.19

314

(3033942) Copper [Moles/time] in 24 hour Urine

134

2.60

8.26

1.2

0.9

0.8

umol/24h

0.04

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

283

1376

1.46

8.24

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

245

1161

1.50

8.11

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

174

2.37

8.10

1.5

10.8

13.7

0.45

128

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

275

2.07

8.09

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

115

2.72

8.08

1.5

1.6

0.0

0.1

u/l

1.02

(3013762) Body weight Measured

111

2.75

8.08

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

296

2.02

7.96

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

108

2.77

7.95

1.1

469.8

326.6

u/l

0.39

(3005082) Progesterone [Moles/volume] in Serum or Plasma

417

2186

1.36

7.94

1.4

28.8

32.2

nmol/l

1.54

373

2016

(3045424) Erythrocytes [Presence] in Urine

889

5144

1.23

7.90

1.6

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

351

1.93

7.89

1.0

0.6

0.8

u/ml

0.13

188

(3016031) Almond IgE Ab [Units/volume] in Serum

227

2.16

7.81

1.0

0.4

0.7

u/ml

0.71

131

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

117

467

1.78

7.67

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

118

473

1.77

7.63

1.7

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

561

3088

1.29

7.62

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

361

1.89

7.59

1.0

0.9

3.3

u/ml

0.68

188

(3027974) Hepatitis B virus e Ag [Presence] in Serum

185

2.27

7.50

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

840

4869

1.23

7.38

1.8

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

311

1.94

7.30

1.3

1.2

—

(3036603) Volume of Urine

367

1913

1.37

7.29

1.5

1.7

1780.7

1955.3

0.89

433

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

1085

1.49

7.27

4.1

3.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

164

1810

0.64

7.22

1.3

—

(3020491) Glucose [Moles/volume] in Blood

422

2251

1.34

7.22

1.7

6.7

6.6

mmol/l

0.30

327

1672

(21491868) Cryoglobulin [Mass/volume] in Serum

218

1035

1.50

7.21

1.3

1.2

0.5

g/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

343

1.89

7.17

2.7

2.5

1.0

1.4

mmol/l

1.03

243

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

153

2.37

7.17

1.1

1.0

—

(3051339) Copper [Moles/volume] in Blood

149

2.39

7.13

1.2

1.3

16.0

16.7

umol/l

0.47

130

(4035726)

3835

24912

1.10

7.07

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

303

1541

1.40

7.00

1.6

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

182

2.23

6.98

1.1

1.2

22.7

17.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

274

1370

1.42

6.97

1.6

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.49

6.88

2.0

2.5

2.1

2.2

mu/l

0.07

(4015189)

146

640

1.62

6.87

2.5

2.3

—

(40768446) Kidney Pathology biopsy report

256

1268

1.44

6.86

2.0

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

231

2.06

6.80

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

275

1384

1.41

6.76

1.6

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

570

3197

1.27

6.74

1.4

11.8

11.7

mmol/l

0.05

182

655

(40759632) Porphyrins [Mass/mass] in Stool

4.95

6.71

1.2

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

271

1.97

6.71

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.16

6.67

1.6

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

191

2.16

6.62

1.3

1.2

5.8

5.1

u/ml

0.06

155

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

473

2598

1.30

6.61

1.4

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

147

2.32

6.49

1.4

1.3

1.5

1.4

0.05

(3016750) Collection duration of Urine

295

1516

1.39

6.45

2.3

2.2

520.3

496.2

min

4.35

224

1158

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

563

3172

1.26

6.44

2.1

32.4

32.6

0.48

556

3148

(3018133) Calcium [Moles/volume] in Urine

121

516

1.67

6.37

1.9

2.1

2.6

2.7

mmol/l

0.15

111

464

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

146

653

1.59

6.37

1.6

1.5

0.4

ug/l

0.16

440

(3052592) Norovirus Ag [Presence] in Stool

118

500

1.68

6.36

1.2

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

358

1.81

6.34

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

190

2.13

6.33

1.0

1.1

7.6

10.2

u/l

0.78

190

(3051593) INR in Capillary blood by Coagulation assay

205

991

1.47

6.28

5.4

9.9

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

123

2.43

6.26

1.5

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

444

2441

1.30

6.19

1.9

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

429

2348

1.30

6.19

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.23

6.19

1.0

0.0

0.1

u/ml

0.28

(4146454)

485

2698

1.28

6.18

2.7

2.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

367

1.78

6.14

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

225

1114

1.44

6.11

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

138

2.32

6.09

1.0

0.2

0.1

u/ml

0.22

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

546

3089

1.26

6.06

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

391

1.75

5.99

1.7

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

296

1544

1.36

5.95

1.7

2.2

2.4

u/field

0.20

210

1125

(40765089) Chromosome analysis panel - Blood by G-banded

248

1256

1.41

5.95

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

203

992

1.46

5.92

1.7

137.3

138.2

au/ml

0.01

129

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

177

842

1.50

5.90

1.6

9.4

8.8

ug/l

0.80

177

842

(3037692) Legionella sp identified in Specimen by Organism specific culture

192

931

1.47

5.83

1.8

1.4

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

221

2.00

5.82

1.1

24.1

26.0

u/ml

0.11

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

221

2.00

5.82

1.1

38.6

31.5

u/ml

0.16

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

239

1209

1.41

5.79

3.1

3.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.54

5.74

1.0

1.1

0.2

g/l

2.93

(3038515) Glucose [Moles/volume] in Venous blood

833

4956

1.20

5.73

3.6

3.0

7.2

7.5

mmol/l

1.43

818

4861

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.69

5.67

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

176

2.10

5.60

1.8

2.2

21.1

19.9

mmol/l

0.16

149

(3017400) Magnesium [Moles/volume] in Urine

3.10

5.60

1.2

1.1

3.2

3.0

mmol/l

0.06

(3020876) Protein [Mass/time] in 24 hour Urine

393

2160

1.30

5.55

2.1

2.0

0.8

1.1

g/24h

0.39

139

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

172

2.11

5.55

1.1

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

412

1.69

5.50

1.3

1.5

97147.9

242658.8

nmol/l

0.58

347

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.55

5.47

1.1

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

334

1.77

5.43

1.0

0.1

0.6

u/ml

1.71

184

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

126

568

1.58

5.39

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

691

4065

1.21

5.39

1.3

1.2

33.5

32.7

u/l

0.05

604

3562

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

100

426

1.67

5.36

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

307

1.78

5.22

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

242

1251

1.38

5.21

2.1

2.0

8.6

9.5

mg/l

1.38

190

1003

(3041672) Baker's yeast Ab [Presence] in Serum

168

2.07

5.14

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4038

26676

1.08

5.13

3.5

4.1

19.8

23.9

ug/l

0.45

3160

21017

(3012898) Urea [Moles/volume] in Urine

288

1.80

5.12

1.6

161.7

173.1

mmol/l

0.34

260

(3016273) Islet cell 512 Ab [Units/volume] in Serum

237

1.89

5.12

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

159

764

1.48

5.12

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

184

2.01

5.03

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

102

445

1.63

5.02

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.23

4.99

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

296

1.78

4.98

1.2

1.1

1.6

3.0

umol/24h

0.61

296

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

395

2206

1.27

4.98

2.0

1.9

—

(3049233) Organic acids panel - Urine

3.79

4.98

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

415

2335

1.27

4.93

1.1

3.2

2.4

u/ml

0.16

142

653

(40757373) Influenza virus identified in Isolate

113

509

1.58

4.90

1.9

1.6

—

(3006462) Nitrate [Presence] in Urine

265

1407

1.34

4.85

3.3

2.8

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

242

1.85

4.83

1.0

0.1

1.1

u/ml

1.28

150

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.55

4.69

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

226

1.86

4.59

1.4

1.3

1.6

ml/s/173m2

0.31

148

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

249

2343

0.75

4.59

1.2

1.3

1.4

1.5

g/l

0.71

109

(36303858) Crystals [Presence] in Urine

3.55

4.58

1.2

—

(3004451) EKG impression Narrative

226

1183

1.36

4.57

1.4

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.56

4.56

1.1

—

(3024263) Appearance of Synovial fluid

261

1399

1.33

4.51

1.9

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

972

5986

1.16

4.50

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

442

1.59

4.49

2.8

2.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

398

1.63

4.48

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

210

1091

1.37

4.46

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

267

1441

1.32

4.41

1.6

4.7

5.8

mmol/24h

0.88

117

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

338

1885

1.28

4.37

2.1

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

970

5989

1.15

4.35

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.37

4.35

1.0

297.1

187.6

pmol/l

0.58

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

108

2.24

4.35

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1024

6350

1.15

4.33

2.5

2.4

123.0

103.8

ug/min

0.52

612

3854

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

215

1129

1.35

4.29

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

211

1.85

4.28

2.9

94.9

400.2

pmol/l

0.43

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

181

1.92

4.27

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

274

1.74

4.25

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

152

754

1.43

4.24

1.4

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

280

1.73

4.21

3.0

2.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

444

1.57

4.21

5.3

5.2

47.7

45.3

ug/min

0.12

346

(3044009) aPTT.lupus sensitive (LA screen)

297

1.70

4.17

1.2

—

(4211845)

283

1554

1.30

4.15

3.2

2.8

—

(40768793) Breast Pathology biopsy report

1123

7042

1.14

4.05

1.3

—

(4094501)

1251

7899

1.13

4.05

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

110

520

1.50

3.94

2.2

5.3

74.9

52.3

u/l

0.33

205

(3018738) Hemoglobin F/Hemoglobin.total in Blood

207

1.82

3.94

2.5

3.1

23.8

10.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

100

2.20

3.86

1.0

1.1

2.1

1.0

u/field

0.42

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.73

3.85

1.2

1.1

1.8

2.7

1.21

(3003129) Base excess in Capillary blood by calculation

130

639

1.45

3.84

1.6

1.7

0.9

0.6

mmol/l

0.46

121

603

(3008536) Aspergillus sp Ab [Presence] in Serum

115

552

1.48

3.84

2.1

2.3

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

209

1.80

3.83

1.0

21.9

18.1

u/ml

0.15

170

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

164

846

1.38

3.72

1.8

1.6

—

364.5

iu/ml

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

116

2.08

3.71

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

207

1.79

3.66

1.1

1.6

1.3

u/ml

0.13

145

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1462

9378

1.11

3.63

3.0

3.6

4663.0

1376.1

u/ml

0.36

1228

8049

(3007916) DNA double strand Ab [Titer] in Serum

388

1.56

3.60

1.3

115.5

154.6

titre

—

(3049242) von Willebrand panel - Platelet poor plasma

2.26

3.57

1.4

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.28

3.53

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

847

5273

1.14

3.48

1.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

341

1.58

3.47

1.1

1.5

—

69.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

148

762

1.38

3.43

1.9

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

468

1.49

3.40

1.7

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

207

1.75

3.39

1.1

1.2

—

(3017704) Immunofixation for Urine

232

1279

1.29

3.39

1.8

1.7

—

(37019676) Renin [Units/volume] in Plasma --supine

2.54

3.39

1.1

1.0

73.4

56.9

mu/l

0.12

(42529582) MDA5 Ab [Presence] in Serum by Line blot

136

692

1.40

3.38

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

136

692

1.40

3.38

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

136

692

1.40

3.38

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

136

692

1.40

3.38

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

192

1.78

3.36

1.3

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

141

723

1.39

3.35

1.8

1.9

42.4

36.0

u/l

0.19

124

650

(3004775) Volume in Urine collected for unspecified duration

350

2029

1.23

3.34

2.4

2.3

688.9

674.7

0.26

263

1414

(3013466) aPTT in Blood by Coagulation assay

204

1.74

3.28

1.1

34.8

36.7

1.70

173

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

225

1242

1.29

3.27

1.5

1.6

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.55

3.25

1.1

1.4

79.0

50.7

e6/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

475

2848

1.19

3.21

2.8

2.3

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

159

1.83

3.18

1.0

1.1

38.5

52.5

u/l

1.45

126

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

224

1242

1.28

3.16

1.5

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

225

1249

1.28

3.15

2.1

58.6

108.0

ug/min

0.86

288

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

453

1.48

3.15

4.1

6.3

68.6

69.4

0.11

354

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.37

3.12

1.0

2.3

0.4

u/ml

0.38

(3014599) Egg white IgE Ab [Units/volume] in Serum

390

2307

1.20

3.07

1.1

1.0

3.2

3.7

u/ml

0.09

114

569

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

293

1689

1.23

3.00

1.9

1.8

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

4.57

2.98

1.1

1.0

18.6

13.3

umol/l

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.21

2.94

4.3

5.6

8.1

6.2

mg/l

0.26

(40762365) Oxygen content in Arterial blood by calculation

414

1.48

2.93

3.1

3.0

14.9

ml/dl

0.07

385

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

164

1.78

2.91

1.1

1.4

1.2

u/field

0.66

116

(3012989) Citrate [Moles/time] in 24 hour Urine

2.33

2.88

1.6

1.4

1.9

2.3

mmol/24h

0.60

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

246

1398

1.25

2.88

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

139

1.84

2.86

1.3

1478.0

1130.2

u/l

0.09

122

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

129

1.87

2.85

1.0

0.2

0.1

u/ml

0.47

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

493

1.43

2.84

2.2

2.4

6.8

7.5

mmol/l

1.31

288

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

460

1.44

2.78

1.1

2.8

3.6

pmol/l

0.35

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

819

5182

1.13

2.71

3.2

3.4

387.7

905.7

u/ml

1.57

732

4717

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.01

2.66

1.0

1.1

193.1

279.8

nmol/l

2.15

(3032641) Amino acids panel - Urine

2.80

2.66

1.2

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

438

2658

1.17

2.64

1.6

1.5

30.8

33.2

0.67

280

1650

(3019174) dRVVT (LA screen)

291

1.54

2.63

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.10

2.62

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.96

2.59

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

373

1.47

2.58

3.1

2.8

23.1

mg/l

0.01

351

(3010144) Erythrocytes [#/volume] in Synovial fluid

424

2572

1.17

2.58

1.4

68299.3

107426.2

e6/l

0.97

309

1748

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

360

2155

1.19

2.56

2.0

1.9

2.2

u/field

0.02

184

982

(36304079) Mucus [Presence] in Urine sediment

4.98

2.56

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

145

1.77

2.54

8.5

9.8

632.3

210.5

e6/l

0.54

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

387

1.45

2.52

2.7

61.7

72.0

pmol/l

0.25

333

(3000034) Microalbumin [Mass/volume] in Urine

411

2494

1.17

2.50

3.0

2.9

62.9

53.9

mg/l

0.25

282

1780

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

162

1.71

2.49

1.1

1.2

—

510.0

—

(3022475) Manganese [Moles/volume] in Blood

195

1.64

2.46

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.95

2.46

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

389

1.44

2.46

2.0

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

408

2479

1.17

2.45

2.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.75

2.39

1.1

1.0

—

(3024316) Viscosity of Plasma

133

1.76

2.34

1.7

1.6

1.5

mpas

0.01

(3007919) Fasciola sp Ab [Titer] in Serum

2.32

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

171

1.66

2.32

1.3

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.24

2.28

1.1

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.97

2.27

1.0

0.0

0.1

u/ml

0.67

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

465

2875

1.15

2.26

1.9

2.0

23.9

24.6

ug/l

0.08

455

2814

(3042628) Porphyrins [Moles/volume] in Urine

4.15

2.25

1.1

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

143

788

1.29

2.24

2.1

2.6

103.9

109.3

ng/l

0.17

435

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

138

757

1.30

2.24

1.1

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.27

2.23

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

178

1009

1.25

2.22

1.2

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

229

1.55

2.22

1.0

1.1

12.7

8.2

u/ml

0.56

163

(40762887) Creatinine [Moles/volume] in Blood

2.20

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

204

1176

1.23

2.20

2.7

3.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

105

1.83

2.17

1.3

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

389

1.41

2.13

1.8

1.7

1.6

1.7

mg/l

0.34

328

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

318

1919

1.18

2.13

6.6

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.37

2.13

1.0

0.1

0.2

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

170

1.63

2.13

3.8

5.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

122

664

1.31

2.11

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

255

1.51

2.11

1.2

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.83

2.11

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.83

2.11

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

193

1.58

2.10

1.7

1.4

347.3

313.5

umol/24h

0.51

193

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

122

665

1.30

2.09

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

987

6411

1.10

2.08

4.6

3.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

122

666

1.30

2.08

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

113

1.76

2.02

2.0

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

113

1.76

2.02

11.5

8.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.61

2.01

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.86

1.96

3.0

3.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

343

2100

1.16

1.96

1.1

1.0

0.7

u/ml

0.06

277

(3001686) Cold agglutinin [Titer] in Serum or Plasma

487

1.34

1.96

1.2

1.4

39.8

167.8

titre

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

169

1.60

1.94

1.1

1.0

3.2

2.7

u/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

367

1.39

1.93

3.3

2.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1082

7085

1.09

1.93

1.9

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

167

958

1.24

1.93

2.5

1.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

290

1.45

1.93

1.1

—

(3045177) Copper [Moles/volume] in Urine

2.18

1.92

1.0

1.1

0.2

0.5

umol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1829

13825

0.94

1.92

2.0

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.11

1.90

1.0

1.1

108.1

95.4

nmol/24h

0.19

(3036670) Protein [Mass/volume] in Synovial fluid

136

764

1.27

1.89

1.3

1.2

39.2

40.1

g/l

0.32

416

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

340

2087

1.16

1.89

1.9

3.6

mg/l

0.01

316

1999

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

420

1.35

1.82

1.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

4.44

1.81

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

384

1.37

1.81

2.2

2.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

144

820

1.25

1.80

1.4

55.6

52.3

0.45

123

702

(3000012) Reticulocyte production index

230

1375

1.19

1.78

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

110

608

1.29

1.76

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

184

0.50

1.72

2.5

2.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.12

1.70

3.1

4.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

263

1.43

1.68

1.4

1.3

178.5

321.2

mg/24h

—

(3012565) Volume of 24 hour Urine

244

1477

1.17

1.66

2.2

1957.4

2016.4

0.31

224

1338

(3000285) Sodium [Moles/volume] in Blood

312

1.39

1.65

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

209

0.54

1.65

1.2

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

169

1448

0.83

1.63

2.0

3.9

3.5

ug/l

0.16

142

1288

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

259

1.43

1.63

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.30

1.60

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.19

1.58

1.6

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

208

1.47

1.57

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

220

1.45

1.56

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

226

1.45

1.56

1.1

24.8

21.3

u/l

0.36

151

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

250

1.42

1.55

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

109

614

1.26

1.54

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

3.05

1.53

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

3.05

1.53

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

107

602

1.26

1.53

1.3

1.2

43.3

55.5

mg/l

0.10

436

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.80

1.52

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

102

1.67

1.51

1.0

0.1

0.2

u/ml

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.13

1.50

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.13

1.50

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.13

1.50

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.13

1.50

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.13

1.50

1.9

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.13

1.50

2.0

—

(3025577) Chromium [Mass/volume] in Blood

166

1410

0.84

1.49

2.1

2.5

2.4

ug/l

0.09

135

1190

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

754

4928

1.09

1.49

3.8

3.5

33.2

37.4

u/ml

0.47

717

4760

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

289

1.38

1.47

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

335

2099

1.14

1.47

1.3

6.3

mmol/l

0.03

305

1943

(3032743) Legionella sp IgG Ab [Presence] in Serum

200

1.46

1.2

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.67

1.44

1.2

1.1

0.1

g/l

0.46

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.84

1.43

1.0

55.0

22.0

umol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.75

1.41

1.2

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.75

1.41

1.1

1.0

0.1

0.2

u/ml

0.48

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.28

1.39

1.3

1.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

105

1.62

1.38

1.1

1.3

1.4

1.1

u/field

—

(3023199) Leukocytes [#/volume] in Pleural fluid

404

2575

1.12

1.36

1.5

4129.9

3577.5

e6/l

0.20

309

1836

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.68

1.35

1.3

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

246

1.39

1.34

1.0

0.1

1.0

u/ml

0.71

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.47

1.32

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

129

1.54

1.32

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

184

1116

1.17

1.30

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

548

3559

1.10

1.29

1.6

53.6

55.2

0.39

342

2275

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.71

1.24

7.4

8.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

336

1.31

1.23

2.4

2.3

0.6

0.7

u/field

0.44

336

(3034891) Synovial lining cells/100 cells in Synovial fluid

227

1406

1.15

1.23

1.5

5.4

3.8

0.57

323

(3034092) Cytoplasmic Ig cells/100 cells in Blood

437

1.27

1.22

11.4

6.6

—

(3009871) Measles virus Ab [Titer] in Serum

193

1184

1.16

1.20

1.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

126

1070

0.84

1.19

3.5

3.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

1.19

0.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

126

1069

0.84

1.18

7.0

6.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

198

1.40

1.17

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.72

1.15

8.2

8.5

46.5

42.6

0.23

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

187

1.41

1.15

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.95

1.14

1.1

149.1

136.1

mmol/24h

0.40

(3029612) Listeria sp Ab [Titer] in Serum

1.68

1.12

1.6

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

323

1.30

1.12

1.3

1.9

1.3

mmol/l

0.27

208

(44786800) Granulocytes/100 leukocytes in Body fluid

255

1.34

1.11

1.2

1.3

25.7

24.3

0.09

197

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

302

1921

1.12

1.11

1.3

649.1

500.5

u/l

0.55

281

1826

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.60

1.11

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

142

1.45

1.07

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.62

1.06

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

161

1.41

1.04

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

265

1.31

1.03

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

421

2742

1.09

1.00

1.4

1.3

128.1

106.0

pmol/l

0.14

165

839

(3047189) Immunofixation for 24 hour Urine

174

1082

1.14

0.96

2.1

1.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

146

1.41

0.95

3.5

3.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

124

752

1.17

0.95

1.3

1.4

59.2

61.3

0.28

101

626

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.87

0.94

1.4

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

177

1.37

0.93

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1358

10096

0.95

0.93

1.8

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.74

0.92

1.1

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

190

1.35

0.91

1.2

1.1

10.0

10.1

mg/l

0.02

173

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.13

0.90

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

118

1.45

0.90

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

554

1.19

0.89

1.4

27.6

28.1

g/l

0.06

428

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

329

1.25

0.88

1.1

1.4

—

(3015183) Erythrocyte sedimentation rate

289

1864

1.10

0.88

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.03

0.87

1.0

—

(46236302) HLA-C [Type] by High resolution typing

119

1.43

0.87

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.83

0.86

1.1

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.83

0.86

2.6

2.5

—

(40758292) HTLV I+II Ab panel - Serum

544

1.19

0.85

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

162

1.36

0.85

1.8

1.6

—

(3035880) pH of Pleural fluid

184

1161

1.13

0.84

1.2

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.65

0.84

1.0

1.3

—

(3022670) pH of Venous cord blood

1.65

0.84

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

127

782

1.15

0.83

2.0

1.9

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

298

1933

1.10

0.82

1.4

5.7

5.5

mmol/l

0.89

281

1828

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.61

0.82

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.78

0.82

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

194

1.32

0.82

1.0

1.1

0.5

10.6

u/ml

0.49

(3042111) Morphology [Interpretation] in Bone marrow Narrative

613

4096

1.06

0.80

1.8

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1129

8391

0.96

0.80

1.4

1.5

—

(40768795) Lymph node Pathology biopsy report

386

2962

0.93

0.79

1.2

—

(3045788) Cell count panel - Pleural fluid

306

1996

1.09

0.77

1.6

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

266

1.26

0.76

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

115

938

0.87

0.75

1.6

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

428

1.20

0.74

1.1

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

185

1.31

0.74

1.3

22.3

22.1

mmol/l

0.07

127

(3007700) Barley IgE Ab [Units/volume] in Serum

173

1.31

0.73

1.0

0.2

9.0

u/ml

0.52

(40760409) HLA-A [Type] by High resolution

118

1.39

0.72

1.0

—

(40760410) HLA-B [Type] by High resolution

118

1.39

0.72

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

180

1.30

0.71

6.0

5.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

588

1.16

0.71

2.1

1.8

1.6

3.6

ug/l

1.44

359

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.56

0.70

2.6

2.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

146

924

1.12

0.68

2.4

1.9

610.2

3071.1

e6/l

1.49

101

617

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.87

0.68

1.2

31.0

30.2

nmol/24h

—

(3023383) Lactate [Moles/volume] in Pleural fluid

102

631

1.15

0.67

1.3

3.6

3.5

mmol/l

0.15

584

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

201

1.27

0.67

4.7

4.9

—

(3051101) Glucose [Moles/volume] in Cord blood

415

0.82

0.65

4.5

5.8

—

(3018291) Platelet Ab [Presence] in Serum

1.60

0.65

1.1

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

1.78

0.65

1.0

0.0

0.1

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

132

834

1.13

0.65

1.4

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

129

814

1.13

0.64

2.3

1.8

4099.3

12702.9

e6/l

1.88

418

(3013862) HLA-DP [Type]

121

1.35

0.64

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

403

1.18

0.64

1.2

1.7

1.8

mmol/l

0.09

234

(3006598) pH of Arterial cord blood

1.49

0.63

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.46

0.62

1.5

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.69

0.61

1.2

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

141

1.31

0.60

1.0

1.2

—

(4133840)

123

980

0.89

0.60

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

352

2340

1.07

0.60

1.5

1.4

50246.3

49588.9

e6/l

0.02

232

1360

(3003434) Protein [Mass/volume] in Pleural fluid

425

2844

1.06

0.59

1.5

1.4

34.3

33.7

g/l

0.39

383

2585

(3034614) HLA Ag [Interpretation]

1.42

0.59

1.7

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

205

1.25

0.59

1.1

1.0

6.7

18.0

iu/ml

—

(40762814) Titanium [Mass/volume] in Blood

416

0.84

0.57

2.0

2.4

4.3

3.9

ug/l

0.15

147

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

303

1.20

0.57

3.1

2.9

1.1

1.3

mg/l

0.40

193

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

724

4923

1.05

0.57

1.4

7.1

7.0

mmol/l

0.76

522

3547

(3012441) Differential panel - Pleural fluid

334

2225

1.07

0.55

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

312

1.18

0.53

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

496

3348

1.05

0.53

1.6

7.9

7.5

mmol/l

2.37

302

1976

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

229

1509

1.08

0.52

1.2

1.3

13.1

14.5

u/l

0.59

208

1395

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.52

0.52

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

191

1.23

0.49

1.2

111.0

104.9

ug/l

0.08

121

(46235168) Fasting glucose [Moles/volume] in Blood

416

0.85

0.49

1.7

6.5

7.4

mmol/l

1.02

124

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

270

1.18

0.48

1.3

33.3

205.9

u/l

0.91

199

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

436

1.14

0.47

1.4

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

148

1.25

0.45

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

115

741

1.10

0.45

1.1

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.46

0.43

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

108

0.72

0.43

1.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.55

0.42

1.6

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

536

3965

0.96

0.40

3.2

3.1

0.8

nmol/l

0.93

396

3060

(21494434) Karyotype in Bone marrow

319

2151

1.05

0.40

1.2

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.36

0.40

1.1

1.2

21.8

29.5

mg/l

1.22

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.38

0.40

2.3

2.1

—

(44806420)

607

1.10

0.38

2.0

2.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

438

1.12

0.38

3.0

2.8

2883.9

1554.0

u/l

0.64

401

(3026692) Albumin [Mass/volume] in Peritoneal fluid

635

1.10

0.37

1.7

1.4

12.4

13.3

g/l

0.38

486

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

319

1.14

0.35

1.3

1.4

8.5

13.3

1.02

166

(3017958) Strawberry IgE Ab [Units/volume] in Serum

108

1.25

0.35

1.0

0.0

0.2

u/ml

0.98

(4281824)

447

3305

0.96

0.35

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

190

0.82

0.35

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1568

10931

1.02

0.32

1.5

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

182

1.17

0.32

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.33

0.30

1.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.28

0.30

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.34

0.29

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

893

6202

1.02

0.28

4.1

3.1

22.0

26.4

mg/l

3.19

547

3831

(3001893) Eosinophils/100 leukocytes in Pleural fluid

641

1.08

0.27

1.3

1.4

3.0

2.9

0.03

548

(3037556) Urate [Mass/volume] in Serum or Plasma

112

746

1.07

0.26

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

452

1.09

0.24

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

610

1.07

0.24

2.5

2.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

560

0.93

0.24

1.2

1.3

64.8

359.8

ug/l

2.81

306

(43055442) Apixaban [Mass/volume] in Serum or Plasma

300

0.90

0.22

1.5

112.9

116.8

ug/l

0.08

244

(3046861) Legionella sp Ag [Presence] in Urine

135

1.16

0.22

1.2

1.1

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.6

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.18

0.20

1.1

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.80

0.20

5.2

6.9

—

(4038314)

319

0.91

0.19

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

312

2154

1.03

0.19

1.3

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

177

0.88

0.18

1.7

0.7

0.6

0.16

132

(3048879) Bone marrow aspiration report

103

696

1.05

0.17

2.2

1.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.13

0.17

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

110

745

1.05

0.17

2.3

1.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

125

1.14

0.17

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

282

1.08

0.17

1.2

1.3

5.4

6.2

mmol/l

0.51

142

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

173

1.11

0.16

2.0

2.3

16.6

17.1

0.02

(3011544) Albumin [Mass/volume] in Pleural fluid

194

1.10

0.15

1.1

19.0

17.4

g/l

0.63

174

(3025315) Body weight

256

1.08

0.15

4.2

4.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

438

0.94

0.15

6.4

7.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

395

1.06

0.14

8.6

8.9

0.4

umol/l

0.01

358

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

107

729

1.04

0.14

1.4

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

202

1.09

0.14

4.7

2.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.82

0.14

1.3

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

141

1.11

0.13

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

217

1.08

0.13

2.1

2.3

40.5

60.8

2.11

132

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

441

3083

1.02

0.12

1.4

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

414

1.05

0.10

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

157

1.09

0.10

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

597

0.96

0.09

12.4

8.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.11

0.08

1.0

1.1

602.9

2090.7

titre

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

117

0.91

0.08

1.0

0.0

1.0

u/ml

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

125

1.08

0.07

1.1

1.0

0.1

0.5

u/ml

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

384

1.04

0.07

3.0

3.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

145

0.93

0.06

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.12

0.06

1.4

4.5

6.1

mg/l

0.14

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

133

1.07

0.06

30.1

13.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

519

1.03

0.06

1.4

25.5

24.1

0.13

438

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

324

0.97

0.05

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

125

873

1.02

0.05

1.2

—

(3003577) Lead [Moles/volume] in Blood

266

0.96

0.05

1.3

1.5

0.2

umol/l

0.25

(3001729) Color of Synovial fluid

208

0.96

0.04

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2843

20159

1.00

0.04

1.7

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

673

0.98

0.04

11.9

8.7

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

135

0.95

0.03

1.0

0.2

0.3

u/ml

0.10

(3045142) Bone marrow Pathology biopsy report

406

2869

1.01

0.03

1.3

—

(4212803)

221

1.03

0.02

1.1

—

(40768806) Pleura Pathology biopsy report

315

2228

1.00

0.02

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

257

1.02

0.01

1.3

1.4

66.9

71.1

0.29

219

(40758358) Immune stain study

133

0.96

0.01

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

104

733

1.01

0.01

1.3

40.1

40.3

0.02

503

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.05

0.00

4.7

5.6

0.2

mmol/l

0.13

(3014891) Appearance of Pleural fluid

272

0.99

0.00

2.1

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

143

0.99

0.00

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

325

2307

1.00

0.00

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.00

0.00

1.0

1.1

—

(3047005) Sodium/Creatinine [Ratio] in Urine

0.00

0.0

2.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.96

0.00

1.2

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

1.7

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.99

0.00

1.5

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.99

0.00

1.2

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.99

0.00

1.5

1.3

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.6

—

4.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_NEUROTIC – Neurotic, stress-related and somatoform disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neurotic, stress-related and somatoform disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints